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The intramyocardial injection of biomaterials is an emerging therapy for myocardial infarction. 
Computational methods can help to study the mechanical effects of biomaterial injectates on the 
infarcted hearts and can contribute to advance and optimise the concept of this therapy. 
The distribution of polyethylene glycol hydrogel injectate delivered immediately after the infarct 
induction was studied using rat infarct model. A micro-structural three-dimensional geometrical 
model of the entire injectate was reconstructed from histological micrographs. The model provides 
a realistic representation of biomaterial injectates in computational models at macroscopic and 
microscopic level.  
Biaxial and compression mechanical testing was conducted for healing rat myocardial infarcted 
tissue at immediate (0 day), 7, 14 and 28 days after infarction onset. Infarcts were found to be 
mechanically anisotropic with the tissue being stiffer in circumferential direction than in 
longitudinal direction. The 0, 7, 14 and 28 days infarcts showed 443, 670, 857 and 1218 kPa 
circumferential tensile moduli. The 28 day infarct group showed a significantly higher compressive 
modulus compared to the other infarct groups (p= 0.0055, 0.028, and 0.018 for 0, 7 and 14 days 
groups). The biaxial mechanical data were utilized to establish material constitutive models of rat 
healing infarcts. Finite element models and genetic algorithms were employed to identify the 
parameters of Fung orthotropic hyperelastic strain energy function for the healing infarcts. The 
provided infarct mechanical data and the identified constitutive parameters offer a platform for 
investigations of mechanical aspects of myocardial infarction and therapies in the rat, an 
experimental model extensively used in the development of infarct therapies. 
Micro-structurally detailed finite element model of a hydrogel injectate in an infarct was developed 
to provide an insight into the micromechanics of a hydrogel injectate and infarct during the 
diastolic filling. The injectate caused the end-diastolic fibre stresses in the infarct zone to decrease 





reduction effect declined as the stiffness of the biomaterial increased. It is suggested that the gel 
works as a force attenuating system through micromechanical mechanisms reducing the force 
acting on tissue layers during the passive diastolic dilation of the left ventricle and thus reducing 
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M3060 30:60 N/m biaxial tension model 
M6030 60:30 N/m biaxial tension model 
M6060 60:60 N/m biaxial tension model 
MAPE Mean absolute percentage error 
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MRI Magnetic resonance imaging 
n Total numbr 
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PCI Percutaneous coronary intervention 
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SD Standard deviation 
𝑆𝑐𝑚𝑝  Computational stresses 
𝑆𝑒𝑥𝑝  Experimental stress 
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𝑇  Sample thickness 
𝑡  Data point 
VInject Volume of the reconstructed injectate geometry 
VS Vinyl sulfone 
VWall Wall volume of original cardiac geometry 
VWall,adj Wall volume of the adjusted cardiac geometry 
𝑊  Strain energy function 
∆𝑢  Change in nodal circumferential displacement  
∆𝑣  Change in nodal longitudinal displacement  
∆𝑥  Change in nodal circumferential coordinates (Chapter 5) 
∆𝑥  Block circumferential surface displacement (Chapter 6) 
∆𝑦  Change in nodal longitudinal coordinates (Chapter 5) 
∆𝑦  Block radial surface displacement (Chapter 6) 
∆𝑧  Block longitudinal surface displacement 
0d Zero day, immediate 
14d 14 days  
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1.1 Problem identification 
Cardiovascular diseases (CVD) will become the leading cause of death by 2020 superseding 
infectious diseases such as HIV, TB, and Malaria. Worldwide and particularly in Africa, the 
improvement of economic and social level has been ranked to be a major cause of increasing the 
risk of CVD (Steyn et al. 2005). Myocardial infarction (MI) is the most common cause of heart 
failure (AHA 2008; Rosamond et al. 2008). Despite the currently available therapies, the mortality 
from heart failure is still large (McMurray and Pfeffer 2005). This condition demands urgent 
alternative therapies. 
The only efficacious treatment currently available is heart transplantation, which however suffers 
from a chronic shortage of organ donations. Considerable investigations have been dedicated 
towards developing new treatments with an emphasis on cell delivery approaches (Fuchs et al. 
2001; Mangi et al. 2003; Zisch et al. 2003). These studies showed promising outcomes, yet the best 
cell type for myocardium repair is still debatable.  Furthermore, the factors causing the 
improvement of the left ventricle (LV) pumping function after cell delivery treatments are still not 
clear. It is not well understood whether this beneficial effect of cell delivery treatment has been a 
result of a) cellular signalling, causing myocardial regeneration, neovascularisation (Fuchs et al. 
2001) or decreased apoptosis (Mangi et al. 2003), b) the mechanical consequence of increasing the 
LV wall thickness (Grossman et al. 1975; Wall et al. 2006), or c) a combination of both cellular 
and mechanical mechanisms. It has been recently shown that injectable non-contractile 
biomaterials may be required for long-term beneficial effects on limiting infarct expansion and 
preventing heart remodelling (Christman and Lee 2006; Dobner et al. 2009; Ifkovits et al. 2010). 
These research findings emphasized acellular biomaterial injectates as a potential therapy for MI. 
However, more investigations are demanded to understand the impact of these injectates on the 
heart mechanics aiming at therapy optimization. 
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The effects of particular mechanical properties of the infarct zone on the ventricular performance 
are different during systole and diastole: a compliant infarct zone impairs systolic ejection as it is 
stretched during systole thereby dissipating work of the non-infarcted myocardium and reducing 
the ventricular pump function (Laird and Vellekoop 1977; Bogen et al. 1980). In contrast, a very 
stiff infarct region may impair the diastolic filling process, by increasing the overall ventricular 
stiffness (Smith et al. 1974), but has little adverse effects on systolic function (Bogen et al. 1980). 
These mechanisms also apply when a biomaterial is injected into the infarcted myocardium. The 
infarct zone is mechanically supported and the structural stiffness of the infarct zone is increased 
by the additional material and the increased wall thickness. The increased wall thickness will lead 
to a beneficial reduction of wall stress and the increased stiffness of infarct zone will not adversely 
affect the systolic ventricular function. The increased infarct stiffness may, however, impair 
diastolic filling and have a counteractive effect on the desired improvement of ventricular 
performance. 
1.2 Aim and objectives 
The aim of this research is the contribution to the understanding and advancement of the emerging 
therapies for acute MI based on the injection of biomaterials into the ischemic myocardium, by 
way of studying the biomechanical mechanisms associated with this treatment. 
The main objectives of this study are: 
1) To establish adequate computational models to simulate myocardial and ventricular 
mechanics.  
2) To investigate the in vivo intramyocardial three-dimensional (3D) microstructural 
spatial distribution of polymeric biomaterial injectate and utilize this geometric 
information in computational models. 
3) To establish constitutive models for infarcted myocardial tissue through biaxial 
mechanical testing. 
4) To computationally simulate the regional micromechanics of myocardium with 
interlaced polymeric biomaterial with particular reference to the infarct zone. 
5) To computationally investigate novel concepts for material-injection based MI 
therapy and preventive interventions for heart failure with regard to the 
biomechanical effects of biomaterial injection, and predict their influence on 
treatment outcomes. 
1.3  Chapters overview 
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1.3 Chapters overview 
The following chapters of this thesis comprise the following: 
Chapter 2 explores the relevant literature in the area of MI biomechanics. Basic cardiac mechanical 
and electrophysiological characteristics are addressed focusing on MI and injectable therapeutic 
biomaterials. Insights into mechanical characterization and computational modelling of 
myocardium are also presented. The chapter concludes with an overview of the established animal 
models for MI studies. 
Chapter 3 presents the approach used to develop a geometrical heart model incorporating the 
in vivo intramyocardial microscopic 3D hydrogel injectate. The 3D model of the hydrogel injectate 
was developed from histological micrographs of an explanted rat heart. A biventricular rat heart 
model was developed from cardiac magnetic resonance imaging data. The two models were 
combined providing realistic geometries for multiscale computational studies. 
Chapter 4 describes the investigation of the passive mechanical properties of infarcted tissue under 
biaxial compression and shear loadings. MI was induced in rat hearts and followed by mechanical 
testing at different time points after infarct induction. Histological analysis was performed to 
confirm the infarcts and to quantify their sizes. Biaxial, shear and compression results were 
presented and analysed. The variation in the mechanical properties of infarcts at different time 
points was discussed. 
Chapter 5 describes the inverse modelling technique and the developed optimisation loops used 
to identify the constants of Fung-orthotropic constitutive model for different infarcts groups. 
A computational model of the biaxial test was developed and verified. Computational results were 
fitted to experimental biaxial data described in Chapter 4. Genetic Algorithms were utilized to 
optimise and search for the best fit.  
Chapter 6 covers the investigation of the micromechanics of the hydrogel injectate in the infarct 
zone utilizing a microscopic geometry of the hydrogel (developed using the method presented in 
Chapter 3) and the infarct material models identified in Chapter 5. An end-systolic LV model was 
developed and used to simulate passive filling of a healthy LV. The mechanics of a small anterior 
wall volume, referred to as block, containing composites of infarcted myocardium and hydrogel 
injectate was captured and analysed. Results were analysed and the mutual mechanical impact 
between infarct and gel of varying stiffness was discussed.  
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Chapter 7 describes the overall findings and conclusions. Recommendations for future work were 
presented. 
1.4 Publications originating from this PhD research 
Chapter 3 represents an extended edition of the following journal paper: 
 Sirry MS, NH Davies, K Kadner, L Dubuis, MG Saleh, EM Meintjes, BS 
Spottiswoode, P Zilla, T Franz. Micro-structurally detailed model of a therapeutic 
hydrogel injectate in a rat biventricular cardiac geometry for computational 
simulations. Computer Methods in Biomechanics and Biomedical Engineering, 
2015. 18(3): p. 325-31. 
The following peer-reviewed abstracts are also direct outcomes of this thesis and have been 
presented at local and international conferences: 
 Sirry MS, Davies NH, Kadner K, Saleh MG, Spottiswoode BS, Meintjes EM, 
Masithulela F, Zilla P, Franz T. Geometrical Modeling of Myocardial Biomaterial 
Injectate in a Rat Heart Utilizing Magnetic Resonance Imaging and Histology, in 8th 
South African Conference on Computational and Applied Mechanics (SACAM). 3rd-
5th September 2012: Johannesburg, South Africa. 
 Sirry MS, Butler JR, Patnaik SS, Brazile B, Bertucci R, Claude A, McLaughlin R, 
Davies NH, Liao J, Franz T. Post-infarct Mechanical Behaviour of Rat Myocardial 
Tissue under Biaxial Tension, Compression and Shear Loads, in 7th World Congress 
of Biomechanics. 6th-11th July 2014: Boston, MA, USA. 
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2 Literature review 
2.1 Anatomy and physiology of the heart 
The heart is a hollow muscular organ specialized in pumping the blood throughout the body. It 
lies in the chest between the lungs. Anteriorly, the heart is supported by the ribs and sternum. 
The thoracic vertebrae and the diaphragm represent the posterior and inferior boundaries, 
respectively, of the heart. The aorta, pulmonary trunk and superior vena cava maintain the heart 
superiorly (Moses et al. 2005). 
 
Figure 2.1: Anatomy of the heart. (a) The four chambers of the heart and the great vessels. 
(b) Coronary arteries and veins. (modified from Moses et al. (2005)) 
Internally, the heart contains four chambers as illustrated in Figure 2.1 (a). During ventricular 
resting state (diastole), the right atrium collects the deoxygenated blood from the body via the 
superior and inferior vena cava while the left atrium collects the oxygenated blood from the lungs. 
From the atria, the blood flows into the ventricles via two atrioventricular valves; the mitral and 
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tricuspid valves. During ventricular contraction (systole) the blood is pumped from the right and 
left ventricles to the lungs and entire body, respectively. 
The cardiac tissue is supplied by blood through a set of small arteries called the coronary arteries, 
Figure 2.1 (b). The left and right coronary arteries originate from the left and right coronary sinuses 
of the aorta, respectively. The left coronary artery divides into the anterior interventricular branch, 
widely known as the left anterior descending (LAD), and the circumflex branch. The LAD supplies 
the anterior wall and the apex of the heart and the anterior two-thirds of the septum (Moses et al. 
2005). 
The heart wall consists of three major layers; the pericardium (outer layer), the myocardium 
(middle layer) and the endocardium (inner layer) as shown in Figure 2.2. The myocardium is a thick 
layer that contains the contracting cardiac muscle tissue and is thus considered to be the functional 
layer of the heart wall. The thickness of this layer varies in the heart depending on the required 
blood ejecting power. Therefore, the left ventricle (LV) comprises the thickest myocardium since 
it pumps the blood to the entire body (Van De Graaff 2001).  
 
Figure 2.2: Layers of the heart wall (Van De Graaff 2001). 
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The cardiac muscle cells (myocytes) and fibres (myofibres) interconnect in parallel and series in a 
unique fashion unlike other skeletal muscle fibres. This interconnection improves the distribution 
efficiency of the action potential throughout the heart (Guyton and Hall 2006).  
The cardiac myofibres have a very complex orientation. The fibres exhibit a global helical 
orientation, Figure 2.3 (a). Moreover, the fibres are arranged in sheets of different fibre orientation 
across the heart wall, Figure 2.3 (b).  This complex orientation of fibres is believed to play an 
important role in the pumping function of the heart by reducing the energy required for pumping 
(Grosberg et al. 2009).  
 
Figure 2.3: Cardiac muscle fibres. (a) Biventricular muscle fibres seen from the apex after removal 
of the most apical parts of the myocardial mass. (b) Free wall of the left ventricle partially 
fenestrated to show the continuous turn of muscle sheets. (modified from Schmid et al. (1997)) 
The cardiac muscle can be divided into three types: atrial muscle, ventricular muscle and specialized 
excitatory and conductive muscle fibres. The atrial and ventricular muscle fibres contract in similar 
way as the skeletal muscle except for their relatively longer contraction duration. The excitatory 
and conductive muscle fibres have a week contraction; however, they exhibit automatic 
induction/conduction of action potentials controlling the rhythmical beating of the heart (Guyton 
and Hall 2006). 
The cardiac cycle consists of two major phases: a muscle relaxation phase called diastole and a 
muscle contraction phase called systole. In a cardiac cycle, a spontaneous action potential is 
generated at the sinus node at the lateral wall of the right atrium. The action potential is propagated 
over the atria inducing atrial contraction. It travels through the specialized conductive fibres, the 
atrioventricular (AV) bundle, to the ventricles inducing ventricle contraction. A delay of 0.1 second 
is presented between the atrial and ventricular contractions. This delay allows the atria to contract 
first and pump the blood into the ventricles which, in turn, pump the blood to the vascular system 
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(Guyton and Hall 2006). As a result of these cardiac events, the pressure and volume change 
continuously during a cardiac cycle. Figure 2.4 illustrates the cardiac cycle and the accompanying 
cardiac events. 
 
Figure 2.4: The cardiac cycle for the left ventricle (Guyton and Hall 2006). 
The continuous loop of blood filling (diastole) and ejection (systole) by the LV is often represented 
by plotting an instantaneous pressure-volume relationship. A typical LV pressure-volume loop is 
shown in Figure 2.5. Following the ejection of the blood, the intraventricular pressure drops 
instantaneously as the ventricle relaxes (isovolumetric relaxation) until it reaches a level where the 
atrial pressure becomes higher. This pressure difference causes the atrioventricular valve to open 
allowing the blood to flow from the atrium to the ventricle (filling).  The ventricular filling is 
associated with the increase in the ventricular volume. The ventricle then contracts and the 
intraventricular pressure increases instantaneously (isovolumetric contraction) causing the aortic 
valve to open. After that, the ventricle volume decreases as the blood is pumped into the aorta 
(ejection) (Burkhoff et al. 2005; Guyton and Hall 2006).  




Figure 2.5: Pressure-volume loop in left ventricle (Burkhoff et al. 2005). 
2.2 Pathophysiology of myocardial infarction 
Myocardial infarction (MI), commonly known as “heart attack” is defined as the “complete 
occlusion (blockage) of coronary artery that deprives the myocardium of oxygen and causes death 
(infarction) of the tissue” (Moses et al. 2005). Occlusion can occur in any of the three major 
channels of the coronary artery or their branches. The size of the blocked vessel and the position 
of occlusion determines the severity of the MI from mild, moderate or severe. Obstruction of the 
left coronary artery before it branches is considered to cause the most serious MI since it affects 
the anterior, left side and a considerable portion of the posterior wall of the heart. The blockage 
of the LAD, which comes second in severity, damages the anterior wall of the heart as shown in 
Figure 2.6. 
The complete or partial occlusion of coronary artery occurs by blood clots. Atherosclerosis is a 
known arterial disease causing hardening of the artery due to plaques (cholesterol deposits) 
formation in the vessel wall. The sudden rupture of the covering of the plaques trigger platelet 
aggregation which, in turn, leads to the formation of blood clots. As a consequence, these blood 
clots obstruct the lumen of the artery inducing acute MI. The main risk factors for atherosclerosis 
and MI include the blood lipid abnormalities (cholesterol and triglycerides), smoking and 
hypertension. The presence of these three factors together in one person increases the risk of 
having MI by tenfold. Other risk factors include family history of atherosclerosis or blood lipid 
abnormalities, male gender, women’s postmenopausal state, diabetes, excess weight, physical 
inactivity, age and insulin resistance (Fuster et al. 2011). 
Possible short-term consequences of MI (Turner 2008) include ventricular fibrillation, cardiogenic 
shock and heart block. Ventricular fibrillation occurs when the infarcted muscle interrupts the 
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propagation of the electrical signal causing a disorganization of the heart rhythm. This can impair 
the heart ability to pump the blood. Cardiogenic shock is the condition when the infarct is so 
massive that the remaining cardiac muscle is not able to pump the blood. The LV is prone to pump 
failure once the area of infarct zone reaches 40% of the LV myocardium (Page et al. 1971; Alonso 
et al. 1973). Heart block occurs when the damaged muscle is in the channel that carries the 
heartbeat signal resulting in impairing the rhythmical beating of the ventricles.  
The infarcted myocardium heals by formation of scar tissue which in turn expands with time. As 
the heart continues to pump, the non-contractile scar tissue stretches passively. The LV wall tends 
to undergo structural changes that lead to dilation, Figure 2.6, and increase in ventricular volume 
and pressure. This long term consequence is called ventricular remodelling, a condition that can 
lead to a heart failure (Turner 2008). More details on remodelling are presented in the following 
section. 
 
Figure 2.6: Left ventricle remodelling. © 2007 Terese Winslow 
2.3 Biomechanics of myocardial infarction and ventricular remodelling 
Healing and ventricular remodelling after MI are dynamic and concurrent processes (Jugdutt et al. 
1996). During the first hours after myocyte necrosis in the ischemic myocardium, oedema and 
inflammation are limited to the infarct region (Pfeffer and Braunwald 1990). This is followed by 
scar formation i.e. fibroblast proliferation and collagen deposition; a process completed after 
weeks to months depending on the species, e.g. 3 weeks in rat (Hochman and Bulkley 1982; 
Roberts et al. 1983; Pfeffer et al. 1991) and 6 weeks in dog (Jugdutt and Amy 1986). During this 
period, the infarcted myocardium can thin and elongate - the process of infarct expansion 
(Hutchins and Bulkley 1978) - which occurs typically prior to the extensive deposition of collagen 
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with an associated increase in tensile stiffness. Thinning of the myocardium is a result of slippage 
between myofibre bundles (Weisman and Healy 1987). The disrupted muscle bundles are 
subsequently connected by connective tissue forming within the vacated myocyte compartments, 
thereby reducing further expansion (Vracko et al. 1989).  
With the aim of providing a basis to the systematic development of MI therapies based on the 
understanding of the mechanical mechanisms involved, Holmes and colleagues presented a 
description of the mechanics of healing myocardial infarcts (Holmes et al. 2005) and distinguished 
four stages of myocardial infarction: i) Acute ischemia (first minutes to hours after infarction), ii) 
Necrotic phase (hours to 5-7 days after infarction), iii) Fibrotic phase (5-7 days to 14-28 days after 
infarction), and iv) Remodelling phase (14-28 days to 28-56 days after infarction). 
Figure 2.7 illustrates the variation in the time points of these stages between species. 
 
Figure 2.7: Temporal span of the phases of healing of myocardial infarction in species (Holmes et 
al. 2005). 
The principal effects of the mechanical properties of infarcted myocardium on the LV function 
are the following (Holmes et al. 2005): 
 Rupture of infarcted myocardium: Infarct rupture presents the most catastrophic failure 
associated with MI and accounts for 15-30% of deaths during the first post-infarction 
week (Birnbaum et al. 2003; Wehrens and Doevendans 2004). The mechanical properties 
related with infarct rupture are not fully understood (Holmes et al. 2005). 
 Stretching and bulging of the infarct zone dissipates energy generated by the non-
infarcted myocardium: The LV is prone to pump failure once the area of infarct zone 
reaches 40% of the LV myocardium (Page et al. 1971; Alonso et al. 1973). This has been 
attributed not only to a reduction of contractile myocardium that contributes to ejection 
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but also to a systolic impairment related to the compliance of the infarcted zone. While a 
stiff infarct has little adverse effects on systolic ejection(Bogen et al. 1980), systolic 
dysfunction is prominent for compliant infarct zones that are stretched during systole 
thereby dissipating work of the remaining non-infarcted myocardium and reducing the 
ventricular pump function (Laird and Vellekoop 1977; Bogen et al. 1980). 
 Increased stiffness of infarcted myocardium may limit the function of 
non-infarcted myocardium during diastole: A very stiff infarct region is reported to 
impair a) the diastolic filling process by increasing the overall ventricular stiffness (Smith 
et al. 1974) and b) the utilization of the Frank-Starling mechanism by the non-infarcted 
myocardium to adjust the ventricular output (Janz and Waldron 1978). Frank-Starling 
mechanism is the mechanism by which the heart increases its stroke volume (blood volume 
pumped from ventricles in a beat) through rising the contraction energy as a result to the 
increase in the end-diastolic volume (Levick 2010). 
 Expansion of infarct zone and dilation of ventricular cavity leads to elevated wall 
stress throughout the ventricle: The expansion, and associated thinning, of the infarcted 
myocardium has a two-fold effect. The thinning leads to an increase of stress in the 
infarcted wall at any given ventricular pressure. The increase in the ventricular volume due 
to infarct expansion results in an additional increase in wall stress not only in the infarct 
zone but also in the non-infarcted myocardium which is required to generate higher wall 
stresses to maintain the ventricular pump function (Weisman and Healy 1987; Bogaert et 
al. 2000). 
 Increased infarct stiffness limits the deformation of the functional border zone: In 
the description of mechanical effects of an infarct above, distinctions with respect to 
myocardial regions and mechanical properties have been binary between: a) infarcted and 
non-infarcted myocardium and b) stiff and compliant infarcted myocardium. As to 
structural properties, healing infarcted myocardium exhibits mechanical anisotropy (Gupta 
et al. 1994; Holmes et al. 1997). On a smaller spatial scale of the infarcted LV, the 
distinction of myocardial regions need to be extended by introducing a so-called 
“functional border zone” at the junction of infarcted and non-infarcted myocardium. The 
functional border zone is characterized by impaired deformation despite normal perfusion 
(Gallagher et al. 1986; Holmes et al. 1997).  
 Infarcted myocardium may initiate ventricular hypertrophy: Over a longer period, 
MI has been described to cause, by way of ventricular remodelling, volume-overload 
hypertrophy in the non-infarcted myocardium characterized by wall elongation and 
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thinning causing a global ventricle dilation (Pfeffer and Braunwald 1990). The triggering 
parameters of volume-overload hypertrophy have not been fully understood (Holmes 
2004) but it is assumed that the material properties of the healing infarct play a dominant 
role in this late process which may ultimately lead to dilated heart failure (Holmes et al. 
2005). 
2.4 Current and proposed therapies for acute myocardial infarction 
2.4.1 Diagnosis of myocardial infarction 
The immediate diagnosis of acute MI is done by electrocardiogram (ECG). ECG readings can 
reflect whether the entire thickness of the heart wall was damaged or only partial thickness. 
Pathological Q waves and ST elevation or depression are indications of MI (AHA 2005). Blood 
tests are performed, typically measuring levels of troponin in the blood (Antman et al. 2000), to 
determine the severity of the damage in the heart muscle. Other diagnostic tools include coronary 
angiography, computerized tomography scanning, magnetic resonance imaging and 
echocardiography (Turner 2008). 
2.4.2 Drug therapy 
Acute MI requires quick intervention since time is an essential factor in successfully preserving the 
cardiac muscle (Maroko et al. 1971; Turner 2008). The first line treatment for acute MI includes 
the administration of antiplatelet agents that dissolve blood clots (thrombolysis). Antiplatelet 
drugs, such as aspirin, are recommended within 30 minutes after the onset of the MI symptoms 
(Lassen et al. 2013). Mortality rate was found to be dramatically reduced when thrombolytic 
treatments were given within the first two hours (Weaver et al. 1993; Boersma et al. 1996).  
Other drugs for the long-term management of MI may include nitroglycerin and beta-blockers 
(AHA 2005). Nitroglycerin reduces the heart stress preventing LV dilation and infarct expansion 
(Mahmarian et al. 1998) while beta-blockers inhibit the effect of the sympathetic nervous system 
reducing heart rate and blood pressure (Bates 2007) therefore reducing the cardiac workload. 
Angiotensin-converting enzyme inhibitors are also commonly used treatments that attenuate the 
LV dilation and filling pressure and thus reduce the work load (Pfeffer 1991). 
2.4.3 Percutaneous coronary intervention 
Percutaneous coronary intervention (PCI), or coronary angioplasty, is a common and preferred 
treatment for acute MI (Bates and Menees 2012). This non-surgical procedure involves 
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subcutaneous insertion of a deflated balloon catheter in the arterial system and guided it with x-ray 
to the occluded coronary artery. The balloon is inflated causing dilation of the occluded artery and 
restoration of the blood flow as illustrated in Figure 2.8 (a).  
Balloon angioplasty is more often associated with simultaneous placement of an endovascular 
stent, Figure 2.8 (b), to support the artery and maintain its patency (Schmitz et al. 1996). PCI can 
prevent the death of the cardiac muscle if performed in a timely manner. Delayed PCI, however, 
can still be useful for preventing future coronary artery occlusion (Turner 2008).  
 
Figure 2.8: Coronary artery angioplasty. (a) Balloon angioplasty. (b) Stent angioplasty. (modified 
from Borade (2013)) 
2.4.4 Bypass surgery 
Coronary artery bypass surgery is another option for managing acute MI and the atherosclerotic 
artery. Native veins or arteries are obtained from the patient body and utilized as grafts to bypass 
the diseased artery restoring the blood supply to the cardiac muscle downstream. Although bypass 
surgery has a great instantaneous outcome, postoperative complications are often experienced 
such as graft failure (Turner 2008).  
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2.4.5 Mechanical support devices 
Late therapeutic intervention, typically greater than three hours, following acute MI may result in 
a complete muscle loss in the affected muscle. In this case the first line interventions are of limited 
benefits (Turner 2008). However, therapies are still in need to prevent or supress the complications 
and consequences of MI in the long term.  
As mentioned earlier in this chapter, LV remodelling is one of the possible complications that can 
lead to a heart failure. Special devices, as shown in Figure 2.9, are utilized to provide mechanical 
support to the heart following MI. The reinforcement exerted by these devices is either 
biventricular; e.g. Acorn and Paracor devices, or applied to the LV only; e.g. Myocor myosplint. 
Use of these devices improves the cardiac performance and suppresses the LV remodelling. 
However, the supporting devices restrain the entire ventricle rather than the infarct zone only. 
This can interfere with the contractile tissue which can affect the pumping function of the heart 
(Clarke et al. 2014).  
As an alternative to the whole ventricle restraints, cardiac patches were utilized to provide local 
support to the infarct zone. Synthetic and tissue-engineered cardiac patches (Liu et al. 2004; Rane 
and Christman 2011) were widely tested as local infarct restraints. In spite of the reported positive 
outcome, cardiac patches have the limitation of interfering with the contractile tissue at the 
functional border zone which influence the motion and contraction in that area (Clarke et al. 2014).  
  
 
Figure 2.9: Devices used to mechanically support the heart. (a) Acorn device (Saavedra et al. 2002). 
(b) Paracor device (modified from Klodell Jr et al. (2008)). (c) Myocor myosplint left ventricle 
device (Raman 2008). 
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2.4.6 Cardiac transplantation 
Cardiac transplantation is presently the only cure for patients with severe heart failure. However, 
cardiac transplantation is limited by the availability of donors, the high cost, the limited capacity 
of the specialized clinics and lifelong immunosuppression (Struck et al. 1985).  
2.4.7 New proposed therapies 
Despite the available therapies, the incidence of heart failure after MI is still high strongly indicating 
the need for new therapies. Aiming at restoring the contractility in the damaged tissue, pre-clinical 
research has been devoted to develop new treatments based on cell delivery approaches (Fuchs et 
al. 2001; Mangi et al. 2003; Zisch et al. 2003; Lutolf and Hubbell 2005). In general, cell therapy 
studies showed encouraging outcomes. However, there is uncertainty about the best cell type for 
myocardium repair and whether the improved LV pumping function is purely caused by the 
injected cell. It has been argued that such improved outcome is due to the mechanical consequence 
of increasing the LV wall thickness (Grossman et al. 1975; Wall et al. 2006). It has been recently 
shown that injectable non-contractile biomaterials may be required for long-term beneficial effects 
on limiting infarct expansion and preventing heart remodelling (Christman and Lee 2006; Dobner 
et al. 2009; Ifkovits et al. 2010). These research findings emphasized acellular biomaterial injectates 
as a potential therapy for MI. One major advantage of biomaterial injection therapy over restraint 
devices and cardiac patches is that it is less invasive and can be applied thoracoscopically or 
intravascularly (Nelson et al. 2011). As such, biomaterial injection is considered to be a promising 
new therapeutic approach for MI.  
2.5 Research in biomaterials injection therapies for myocardial infarction 
Biomaterial injection therapy is an emerging approach for the treatment of MI. The procedure 
involves injecting a biocompatible material (biomaterial) into the infarcted zone of the heart wall. 
The injectate provides the required mechanical reinforcement to the infarcted tissue. In addition 
to the mechanical support, the biomaterial injectate can achieve biological improvements when it 
is used as a carrier to deliver stem cells or drugs (Nelson et al. 2011). Theoretically, the biomaterial 
injectate can play a two-fold role in improving the heart function: (1) mechanically supporting the 
damaged tissue preventing remodelling, while (2) delivering growth factors and stem cells that can 
repair the damaged myocardium.  
The early investigations of injection therapy utilized biological materials such as collagen (Dai et 
al. 2005), chitosan (Lu et al. 2009), fibrin (Christman et al. 2004) and alginate (Landa et al. 2008). 
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Synthetic materials, such as synthetic hydrogels (Dobner et al. 2009; Jiang et al. 2009), were also 
investigated. The advantage of using the synthetic over the biological materials is the ability to 
control the material properties to meet a specific requirement; e.g. biodegradability and stiffness. 
However, the biocompatibility of synthetic materials is challenging (Nelson et al. 2011).  
Cell therapy for MI (Atkins et al. 1999; Strauer et al. 2002; Tomita et al. 2002; Kawamoto et al. 
2003) has shown small but beneficial improvements in the mechanical function of the LV, in most 
cases independent of the cell type used. It has been hypothesized that the introduction of 
additional material into the infarcted myocardium exhibits beneficial effects on ventricular 
performance based on passive mechanical support and irrespective of cellular and/or 
electromechanical activity. In conjunction with the potential advantages of acellular MI therapies 
over cell therapy, e.g. reduced immune rejection, greater safety, reduced costs, it has been suggested 
that biomaterials on its own may be of great importance for future MI therapy approaches and 
cardiac therapy in general (Gaudette and Cohen 2006). A study of the short-term mechanisms 
responsible for LV post-infarct improvement after biomaterial injections into the heart was 
presented by Wall et al. (2006). Three different injection modes, namely single injection into 
anterior border zone, multiple border zone injections and single injection into the infarct zone, 
were investigated with various injections volumes and a range of mechanical properties of the 
injectable biomaterial. A three-dimensional (3D) finite element (FE) method for large elastic 
deformation of ventricular myocardium (Costa et al. 1996) and a constitutive model representing 
the passive and contractile anisotropic mechanical properties of healthy and impaired myocardium 
(Guccione et al. 1995) were implemented in a validated FE model previously proposed for an 
ovine heart by Walker et al. (2005). Biomaterial injection was represented by regional adjustment 
of the FE mesh to simulate local bulging and active contractility of the simulated injection site was 
reduced to account for non-contractility of the injected volume. The latter was only required for 
injections in the functional border zone whereas the infarct zone did not exhibit active contractility. 
The effects of the injected material on the LV mechanics was assessed by means of predictions of 
myocardial fibre stress and cardiac performance metrics such as end-systolic and end-diastolic 
pressure volume relationships (ESPVR, EDPVR), ejection fraction, stroke volume end-diastolic 
pressure relationship, and stroke volume end-diastolic volume relationship. This study has shown 
a number of important findings for acellular and cellular MI therapy approaches: 
 Small amounts of injected biomaterial (0.5-5.0% of total myocardial volume) can alter 
cardiac mechanics, reduce wall stress and affect cardiac performance measures. 
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 Improvement in long-term ventricular mechanics may be achieved by passive reduction in 
local stress instead of adding contractile elements in the infarct zone 
 Improvement of cardiac performance metrics may be superficial, due to geometrical 
changes associated with material injection, without a true improvement of global pump 
function. This is an important finding also with regard to cell therapy studies reporting on 
improvement of cardiac performance. Volumes injected during cell therapies have 
exceeded those simulated from Wall et al. (2006) and cardiac performance improvements 
reported may only be due to change in local ventricular geometry rather than the cell 
therapy. Here it is important that the performance metrics are selected, e.g. ESPVR, so as 
to adequately consider changes in ventricular geometry. 
2.6 Myocardial infarction in animal models  
Preclinical investigation of new treatments for human often involves animal models. Researchers 
have been using different animal models in MI and heart failure studies. Since the human is the 
target subject of these investigations, it is very important to select animal models whose 
pathophysiology is similar to human. Concurrently, economical and time consumption 
considerations might influence the selection of an animal model.  
Large animals such as pigs have been ranked superior to small animals such as rats because of size 
and weight similarities between the human and pig heart particularly in extrapolating results from 
animal models to human (Pérez de Prado et al. 2009). However, rat heart follows the anatomy and 
pathophysiology of the human heart (Goldman and Raya 1995). Rats also require less laborious 
and surgical facilities, they are much cheaper and one can easily obtain histology samples from 
their relatively small hearts (Fishbein et al. 1978). Therefore many investigators have shown a great 
interest in using rat models for MI studies with the LAD coronary occlusion being the preferable 
technique to induce infarction (Fishbein et al. 1978; Zimmer et al. 1990; Goldman and Raya 1995; 
Crowley 1997; Wise et al. 1999; Abarbanell et al. 2010). 
In connection with biomechanics, the mammalian cardiac geometry has been studied most 
extensively in dogs (Nielsen et al. 1991; Pao and Ritman 1998) but has also been described for 
other animal species such as sheep (Guccione et al. 2001; Moustakidis et al.), rabbit (Vetter and 
McCulloch 1998; Vetter and McCulloch 2000), and rat (Crowley 1997; Wise et al. 1999). 
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2.7 Computational cardiac biomechanics and electrophysiology 
The primary function of the heart, pumping blood through the circulatory system, is fundamentally 
mechanic. The pumping cycle of the heart consists of passive (resting) and active (contracting) 
processes the mechanics of which is dissimilar. The cardiac biomechanics of the normal heart, and 
the computational methods such as the FE method, have been described at various levels from 
laying out the principles of continuum mechanics and electrophysiology and approaches of 
approximation and discretization of the underlying FE method (Usyk and McCulloch 2003; 
McCulloch and Paternostro 2005) to the application of these computational methods to pre-
clinical and clinical questions (Vetter and McCulloch 1998; Vetter and McCulloch 2000; 
Bettendorff-Bakman et al. 2006; Dorri et al. 2006; Tendulkar and Harken 2006; Delhaas et al. 2008; 
Kroon and Holzapfel 2008). The stresses and strains in the myocardial wall play a central role in 
the cardiac mechanics as they affect many physiological factors such as pumping performance, 
myocardial oxygen demand, and coronary blood flow. The main determinants of myocardial 
stresses and strains are:  
 The cardiac geometry, most importantly the ventricular geometry. 
 The structure of myocardial tissue. 
 The loading conditions (e.g. filling pressure, arterial pressure, and ventricular volume). 
 The constraints or boundary conditions (e.g. pericardial and thoracic environment).  
 The material properties of the myocardium (passive properties, active properties). 
Loading conditions of the heart, and most importantly the LV, have been defined with circulatory 
models of varying complexity. The basic parameters in cardiac mechanics are blood pressure, 
volume and flow rate in the major cardiac chambers. From the point of myocardial wall stress and 
strain, ventricular pressure is most relevant. Typically, the pressure in the LV is presented either in 
association with the aortic pressure (constituting the LV afterload) or as ventricular pressure-
volume relationship. Afterload models have often been considered in cardiac mechanics 
computations (Usyk et al. 2001; Usyk et al. 2002; Kerckhoffs et al. 2003; Watanabe et al. 2004). 
The best-known models for LV afterload are two- and three-element Windkessel models (Frank 
1899; Broemser and Ranke 1930; Westerhof et al. 1973; Stergiopulos et al. 1999). The LV preload, 
i.e. the ventricular filling pressure, has received less attention with regards to model representations 
(Kerckhoffs et al. 2006) and the incorporation in computational models of cardiac mechanics 
(Watanabe et al. 2004). 
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Quantitative information on the external constraints of the heart, such as the surrounding 
pericardium and its attachment and effects of inspiration and expiration, are not widely reported 
and appropriate estimations have been employed in computational studies (Dorri et al. 2006). 
Resting myocardium is often modelled as transverse-isotropic (Humphrey et al. 1990a; Humphrey 
et al. 1990b) finite elastic material using a hyperelastic pseudo-strain function (Fung 1993) and the 
assumption of incompressibility (Usyk and McCulloch 2003). Extension of transverse isotropy to 
material orthotropy has been reported (Usyk and McCulloch 2003). The assumption of 
incompressibility is reasonable for isolated myocardium but may not be sufficient for the intact 
heart that can exhibit considerable redistribution of myocardial tissue volume under physiological 
conditions associated with phasic changes in regional coronary blood supply (McCulloch 2005). 
For active (contractile) properties of the cardiac muscle, a number of models have been suggested 
which include variable elastance formulating the active cardiac force as a function of muscle length 
and time (Suga et al. 1973; Arts et al. 1979; Chadwick 1982; Suga 1990; Taber 1991; Kerckhoffs et 
al. 2007), Hill-type models in which the active fibre stress varies with shortening or lengthening 
(Arts et al. 1982; Nevo and Lanir 1989) and fully history-dependent models generally based on 
Huxley’s cross-bridge theory (Panerai 1980; Landesberg and Sideman 1994a; Landesberg and 
Sideman 1994b; Landesberg et al. 1996). An alternative history-dependent approach is the fading 
memory model (Hunter et al. 1998) which exhibits less biophysical complexity than the cross-
bridge models.  
Comprehensive reviews of computational strategies for cardiac electrophysiology as a framework 
for modelling the cardiac function have been presented by Belik et al. (2004) and Kerckhoffs et al. 
(2006). Structurally and functionally integrated models of cardiac electromechanical functions, 
combining cellular system models and anatomical multiscale simulations, have received particular 
attention in these reviews. At cellular level, the action potential has been modelled 
phenomenologically, e.g. with the FitzHugh-Nagumo equations (FitzHugh 1961; Nagumo et al. 
1962), or biophysically deriving from change in transmembrane ionic currents (Noble and Rudy 
2001; Belik et al. 2004) most of which are based on the formulation by Hodgkin and Huxley (1952). 
Advanced models (Luo and Rudy 1994a; Luo and Rudy 1994b; Jafri et al. 1998; Viswanathan and 
Rudy 1999; Pandit et al. 2001; ten Tusscher et al. 2004; Healy and McCulloch 2005), developed for 
various species including rat (Pandit et al. 2001), consider transmural heterogeneity in 
electrophysiological properties and represent the mechanisms more realistically than Hodgkin-
Huxley formulations which however comes at a larger computational expense. Tissue models of 
cardiac electrophysiology integrate cellular formulations into larger scale models and either treat 
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cells as discrete units (van Capelle and Durrer 1980; Leon and Horacek 1991) or as syncytium 
(Geselowitz and Miller 1983; Henriquez 1993) in mono-domain and bi-domain models; the latter 
of which distinguish between intracellular and extracellular space. Tissue models have been 
employed to study ischemia (Pandit et al. 2001). FE based implementation of the mono- and bi-
domain models has not been able to capture the discontinuous nature of cardiac propagation 
which has been overcome using a finite volume implementation (Trew et al. 2005). Bi- and mono-
domain models have been used to simulate electrophysiology at organ level, i.e. in the whole heart. 
Typically, simplified representations of ionic/cellular phenomena were used in whole heart models 
due to excessive computational demand at organ level. Rosolen et al. (2006) proposed different 
numerical strategies of cardiac electrophysiology based on the FE method to describe the 3D 
electrical propagation in realistic ventricular geometries. They utilized the FitzHugh-Nagumo 
model (FitzHugh 1961; Nagumo et al. 1962) and a bi-domain model. Limitations of the solutions 
were encountered with respect to the prediction of physiological un-realistic isotropic propagation 
patterns but were ascribed to the use of isotropic diffusion tensors. An integrated computational 
model combining electrical excitation and propagation of the myocardium with fluid-structure 
interaction models of the myocardium and the blood volume has been presented by Watanabe et 
al. (2004). Here, the FitzHugh-Nagumo model was used with a mono-domain propagation model 
(Hodgkin and Huxley 1990). Electrophysiology in the context of ischemia has also been 
investigated at organ level (Rodriguez et al. 2004). 
2.8 Computational modelling of myocardial infarction and ventricular 
remodelling 
Mazhari et al. (Mazhari et al. 1998; Mazhari and McCulloch 2000; Mazhari et al. 2000) presented a 
FE model to simulate LV filling and ejection and associated wall stresses in presence of myocardial 
infarction due to LAD and left circumflex (LCx) coronary occlusion. The geometry and myofibre 
orientation of the model were based on comprehensive measurements with a 3D digitizing probe 
on an entire explanted canine heart (Nielsen et al. 1991; Mazhari et al. 1998). The myocardial 
constitutive model used was based on bi-axial test data (Lin and Yin 1998). To model ischemia in 
the infarcted region, the intercellular calcium concentration was decreased so as to result in 50% 
maximum activation (Hunter et al. 1998). A stepwise transition was employed at the perfusion 
boundary. The numerical predicted differences in end-systolic strains and the border zone width 
between LAD and LCx occlusion infarcts compared well with their experimental observations 
(Mazhari et al. 2000).  
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Moustakidis et al. (2002) and Guccione et al. (2001) conducted FE simulations to study the local 
mechanics of the functional border zone in the infarcted LV of a sheep 10 weeks post-infarct. 
Geometric information of the LV shape and location of the border zone were obtained using 
magnetic resonance imaging (MRI) and used two-dimensionally (Moustakidis et al. 2002) and in 
conjunction with 3D reconstruction (Guccione et al. 2001). Moustakidis et al. (2002) measured the 
intracavity pressure using intraventricular Millar® catheter and utilized the measurements as 
loading. A nearly incompressible, linear elastic and isotropic myocardial material model was 
utilized. The border zone was distinguished from healthy myocardium anatomically (through 
varying the wall thickness) rather than functionally. The simple material model, owing to the lack 
of access to more refined data, was stated by the authors as a main limitation of this computational 
work. Guccione et al. (2001) used more advanced constitutive models distinguishing between 
passive (transverse isotropic strain energy potential) and active myocardial properties (cellular 
electrophysiological constitutive equation and time-varying elastance) and utilized the latter to 
simulate loading by ventricular contraction. They represented the infarction by omitting contractile 
tissue properties in the ischemic zone and scaled contractility from 0 to 100% in the functional 
border zone from infarct to non-infarcted myocardium. Comparing three different cases: a) 
normal border zone contractility and infarct material properties, b) reduced border zone 
contractility and infarct material properties, and c) reduced border zone contractility and stiffened 
infarct, it was concluded that the mechanical impairment of the LV infarct border zone is 
predominantly caused by contractile dysfunction of the myocardium rather than increased wall 
stresses.  
A similar approach followed by Walker et al. (2005) to investigate the LV aneurisms in a sheep 22 
weeks post-infarct. LV geometry and myofibre orientation were analysed with tagged MRI (with 
concurrent Millar® catheter intra-LV pressure measurement). The passive and contractile 
mechanical properties of the myocardium were modelled in a similar fashion as to Guccione et al. 
(2001). End-systolic and end-diastolic pressure measured intraventricularly was used to load the 
model after offset of the minimum LV pressure. Material properties were determined with a 
semi-inverse approach applying the loading to the FE model with initial material properties which 
were subsequently adjusted to match resulting configuration of the model with those recorded 
experimentally. Increases of 24% in fibre stress and 115% in cross-fibre stress in the border zone 
compared to remote myocardial regions were demonstrated. It was concluded that active cross-
fibre stress is an integral part of the LV systolic mechanics that needs to be included in FE analyses.  
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Aikawa et al. (2001) presented a FE study of post-infarct LV remodelling in association with an 
echocardiographic clinical trial. Patient-specific (n = 64) LV geometries were pseudo-
reconstructed from orthogonal echocardiographic views obtained 14 days after the myocardial 
infarction. For the simulations, LV end-systolic pressure loading was approximated with systolic 
pressure values recorded during echocardiography. Similar to the study of Moustakidis et al. (2002), 
myocardial material properties were represented in a very simplified fashion as homogenous, 
isotropic, and incompressible. It was concluded from the numerical predication that the apical LV 
wall stress at day 14 post-infarct can serve as predictor for LV dilation during the subsequent 11 
weeks. However, the combination of the simplified 3D representation of the LV and the simplified 
material properties constitute the major short-coming of this study. 
Wenk et al. (2011a) extended a nonlinear optimization method (Sun et al. 2009) to computationally 
investigate the LV contractility and the associated stress distribution in a sheep model with 
posterobasal MI. The LV geometry was developed from short- and long-axis tagged MRI data. 
The systolic circumferential strain which was calculated from the MRI images was used to 
determine the infarct region and approximate the border zone. Optimization of active material 
parameters for different regions was performed by comparing the model-predicted results to the 
experimentally measured values and minimizing the errors. 
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3 Micro-structurally detailed model of a 
therapeutic hydrogel injectate in a rat 
biventricular cardiac geometry 
3.1 Introduction 
In attempts to improve the understanding of the underlying mechanisms, computational models 
have been utilized to study the mechanical effects of injecting biomaterials into the heart. Wall et 
al. (2006) investigated injections into infarct zone and border zone with various injection volumes 
(0.5-5% of total myocardial volume) and a range of mechanical properties of the injectable 
biomaterial. The injectates were represented by local adjustment of the finite element mesh. This 
study showed that small amounts of injected biomaterial can alter cardiac mechanics, reduce wall 
stress and affect cardiac performance. Wenk et al. (2009) developed a method to optimize the 
pattern of multiple injection of a polymeric biomaterial. The results indicated an intuitive injection 
pattern with the greatest number of inclusions when aiming at minimising the mean end-diastolic 
(ED) and end-systolic (ES) myofibre stress but ignoring the LV stroke volume. A non-intuitive 
pattern was, however, found as optimum when both myofibre stress and stroke volume were 
considered. Wenk et al. (2011b) investigated the treatment of an LV infarct with the injection of a 
calcium hydroxyapatite-based tissue filler and demonstrated an increase of ejection fraction and a 
reduction of ED and ES fibre stress in the remote and infarct regions for the treated case compared 
to the untreated case.  
These three studies demonstrated benefits that can be derived from computational models for the 
improvement of MI therapies utilizing myocardial injections. However, the biomaterial injectates 
were simulated either in a ‘smearing’ approach by adjusting wall thickness and constitutive 
properties of the region of injection but without geometrically representing the injectate (Wall et 
al. 2006; Wenk et al. 2011b) or in injectate patterns difficult to be achieved in vivo (Wenk et al. 
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2009). Kortsmit et al. (2013) implemented the discrete layer-wise configurations of the myocardial 
injectate in computational models to emulate, also still simplified, striated injectate distributions 
observed in vivo (Dobner et al. 2009; Ifkovits et al. 2010; Kadner et al. 2012). 
In this chapter, the distribution of polyethylene glycol (PEG) gel injections in infarcted 
myocardium was investigated in a rat model. The three-dimensional (3D) geometry of the hydrogel 
injectate in the infarcted myocardial region of the LV was obtained using histological methods, 
microscopic imaging and 3D image reconstruction. Particular emphasis was placed on a high 
spatial resolution of the injectate to enable a realistic representation in computational models both 
at macroscopic and microscopic level. A rat biventricular cardiac geometry was reconstructed from 
cardiac magnetic resonance (CMR) image data. A combined 3D model of a rat heart with an LV 
biomaterial injectate was developed. 
3.2 Materials and methods 
3.2.1 PEG hydrogel preparation and labelling 
Vinyl sulfone (VS) functionalized PEG gels (20kDa, 8arm) were manufactured as described by 
Dobner et al. (2009). Per gel, 1 µl of 10mg/ml Alexa Fluor® 660 C2 maleimide (Invitrogen 
Molecular Probes, Eugene, Oregon, USA) in dimethyl sulfoxide (DMSO, Sigma-Aldrich Chemie 
GmbH, Steinheim, Germany) was added to 1 µl of 15.4 mg/10 ml dithiothreitol (DTT, Sigma-
Aldrich Chemie GmbH, Steinheim, Germany) in iso-osmotic phosphate buffered saline (iPBS, 
0.15M, pH 7.5) and reacted for 30 min at 37ºC. Gels of 10% (m/v) nominal concentration were 
prepared by dissolving 10 mg of 20 PEG-8VS in 25 µl iPBS and adding 1 µl of the above 
Alexa/DTT solution. The pre-polymer was cross-linked with 3.45 mg MMP-1 degradable peptide 
(GenScript USA Inc., Piscataway, NJ, USA) in 75µl iPBS, then aspirated into a syringe and injected 
into the myocardium before the components were able to polymerize. 
3.2.2 Induction of myocardial infarct and injection of PEG hydrogel 
The animal experiments were approved by the Institutional Review Board of the University of 
Cape Town and performed in accordance with the National Institutes of Health (NIH, Bethesda, 
MD, USA) guidelines. Surgical procedures were performed according to Huang et al. (2006). In 
brief, male Wistar rats (180-220 g) were anaesthetized with a mix of oxygen and 5.0% Isoflurane 
(Safeline Pharmaceuticals (Pty) Ltd., Johannesburg, South Africa), intubated with a 16G 
intravenous catheter (B. Braun Melsungen AG, Melsungen, Germany) and placed onto a heated 
operating board (Braintree Scientific, Inc., Braintree, MA, USA). Throughout surgery the animals 
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were ventilated (112 breaths/min) while anaesthesia was maintained with a mix of oxygen/2.0% 
isoflurane. The heart was exposed via left thoracotomy performed along the 4th intercostal space. 
After pericardiotomy, myocardial infarction was induced by permanent ligation of the left anterior 
descending coronary artery with a 6-0 non-absorbable polypropylene ligature (Ethicon Inc., 
Somerville, NJ, USA) 3 mm distal the auricular appendix. Discolouration of the anterior ventricular 
wall and reduced contractility were hallmarks of a successful occlusion of the artery. Immediately 
after infarct induction, animals received 100 µl 20PEG-8VS cross-linked with MMP1-degradable 
peptide via injection into the infarcted area of the myocardium. After allowing for dispersion and 
in situ polymerization of the PEG gel for 30 min, animals were humanely killed. The hearts were 
carefully harvested and thoroughly rinsed with saline (Adcock Ingram Critical Care, Johannesburg, 
South Africa). 
3.2.3 Tissue processing, sectioning and histological image acquisition 
The hearts were mounted onto chucks and snap frozen in liquid nitrogen (Air Liquide (Pty) Ltd, 
Germiston, South Africa). Sectioning was performed on a cryostat (Microm, Heidelberg, 
Germany) from the apex towards the base of the heart, taking two adjacent 30µm sections at 20 
levels with an inter-level distance of 200µm. Sections were dipped into phosphate buffered saline 
and mounted using DAPI mount (Vector Laboratories, Burlingame, CA, USA). Microscopic 
images were acquired with an Eclipse 90i Fluorescent Microscope with digital camera DXM-1200C 
and fluorescein isothiocyanate filter (all Nikon Corporation, Tokyo, Japan) at 3.2x magnification 
and stitched (NIS Elements BR 3.0, Nikon, Corporation, Tokyo, Japan) to obtain composite 
images of the entire short-axis cross section of the heart at each level. 
3.2.4 Geometrical reconstruction of myocardial injectate 
Histological images of the heart closest representing the observation in previous studies (Dobner 
et al. 2009; Kadner et al. 2012) were utilised for the reconstruction. Short-axis cross section 
composite images of 20 histological sections in cardiac longitudinal direction were imported in 
Adobe Photoshop CS3 (Adobe Systems Inc, San Jose, CA, USA), stacked and aligned to represent 
the in vivo configuration. The region containing the PEG gel was cropped in each image and the 
resulting image stack was imported in Simpleware (Simpleware Ltd., Exeter, UK). The appropriate 
in plane resolution and the section-to-section distance were defined by setting the x, y and z 
spacing parameters to 0.002, 0.002 and 0.245 mm, respectively. The x and y spacing values were 
acquired from a calibration scale image captured at 3.2x magnification whereas the z spacing value 
was obtained from the level distance of the cryo-sectioning process. Image noise and artefacts 
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were reduced using bilateral filters (width= 3 pixels in each direction, sigma range= 120). Two-
dimensional (2D) spatial segmentation masks were developed for the gel injectate in the individual 
images using region-growing segmentation algorithms (Simpleware 2014). Through stacking of 
these 2D masks, a 3D geometric model of the PEG gel was developed. 
3.2.5 Reconstruction of biventricular cardiac geometry 
CMR image data from a healthy rat were utilized to reconstruct a 3D biventricular geometry of a 
rat heart. The image data was obtained in a related study (Saleh et al. 2012) using a custom built 
transmit-receive small-animal bird cage coil with 70 mm diameter in a 3.0T Magnetic Resonance 
Imaging (MRI) system (Allegra, Siemens Healthcare, Erlangen, Germany). An ED short-axis 
image stack was imported in Simpleware utilising the spatial parameters encoded in the CMR 
images. Gradient anisotropic diffusion and gradient magnitude filters were employed to reduce 
image noise and enhance the appearance of endocardial and epicardial edges. 2D spatial masks of 
the myocardium were developed using a combination of intensity thresholding and region growing 
segmentation algorithms. The 2D masks were stacked and the 3D biventricular end-diastolic 
geometry was reconstructed. 
3.2.6 Combining cardiac and injectate geometries 
The anterior wall of the LV of the reconstructed cardiac geometry required adjustment to simulate 
local wall thickening associated with the hydrogel injection. The wall thickness was increased 
locally by adjusting the 2D masks at the epicardium and endocardium of the LV. The overall 
adjusted cardiac geometry fulfilled the assumption: 
WaW lal ll,a InjectdjV  V  V    
where VWall,adj is the wall volume of the adjusted cardiac geometry, VWall is the wall volume of the 
original cardiac geometry and VInject is the volume of the reconstructed injectate geometry. 
Subsequently, the reconstructed injectate geometry was embedded at the predefined injection site 
in the anterior LV wall of the adjusted cardiac geometry. 
3.3 Results 
Figure 3.1 (a) shows one histological image of the cross-sectional region of the LV wall with the 
hydrogel injectate. Image filtering reduced artefacts and noise in the original acquired histological 
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micrographs, Figure 3.1 (b) and the application of the 2D spatial masks enhanced the striations of 
the gel injectate as shown in Figure 3.1 (c).  
 
Figure 3.1: (a) Fluorescent image of the cross-sectional region of the LV wall injected with Alexa 
Fluor® 660 labelled hydrogel. Nuclei appear blue and hydrogel appears pink. (b) Histology image 
after conversion to greyscale and image filtering to reduce artefacts and noise. The hydrogel 
appears white. (c) Selection of the hydrogel and enhancement of the striations by means of a spatial 
masks appearing in green. 
The injectate geometry reconstructed from a set of 20 micrographs is illustrated in Figure 3.2 (a). 
The microscopic structure obtained from the reconstructed geometry, Figure 3.2 (b), closely 
resembled the striated micro-structure of the gel injectate observed histologically in Figure 3.2 (c). 
Figure 3.3 (a) shows the set of CMR images at ED time point with contour lines drawn at the epi- 
and endocardial surfaces of the left (green and red) and right (aqua and violet) ventricles. The 
stages of image processing of each short-axis CMR slice for the 3D reconstruction of the cardiac 
geometry are illustrated in Figure 3.3 (B-D): The original acquired CMR image, Figure 3.3 (b), 
underwent filtering, Figure 3.3 (c), after which a 2D spatial mask was applied, Figure 3.3 (d). 
 
Figure 3.2: The three-dimensional reconstructed injectate geometry (a). A close-up of the injectate 
geometry (b) reveals that it was feasible to represent the in situ micro-structural striations of the 
hydrogel (c) during the reconstruction process. 




Figure 3.3: Set of eight CMR images of a rat showing short-axis views of the heart at ED time 
point. The epi- and endo-cardial contours are delineated in green and red, respectively, for the left 
ventricle and in aqua and violet, respectively, for the right ventricle (a). Close-up short-axis views 
of the rat heart: Original image (b), image after filtering for reduction of noise (c) and filtered image 
with spatial mask identifying the cardiac tissue (d). 
The implementation of the LV anterior wall thickening at the site of the gel injection is illustrated 
in Figure 3.4. Using a 2D mask for the LV, the heart wall was adjusted locally on the epicardial 
and endocardial sides (see bottom part of Figure 3.4) over a distance of 5 mm along the 
longitudinal axis of the heart. This extension matched the in situ height of the injectate of 4.9 mm 
representing approximately 40% of the distance between apex and base of the rat heart. 




Figure 3.4: Illustration of the adjustments (in green) of the anterior wall of the reconstructed 
cardiac geometry (in red) to account for the myocardial injectate: The 2D spatial masks were 
appended locally at epicardial and endocardial sides to generate a local wall thickening.  
The biventricular cardiac geometry as reconstructed from the CMR image data at ED time point 
is illustrated in Figure 3.5 (a). The reconstructed geometry exhibited a myocardial wall volume of 
544 mm3. The result of the local adjustments of the anterior LV wall thickness, i.e. bulging at the 
predefined injection site of the PEG gel, can be observed in Figure 3.5 (b). The wall thickness 
adjustment increased the total wall volume in the biventricular geometry to 579 mm3. The 
combined model with the PEG gel geometry embedded in the cardiac geometry at the injection 
site is illustrated in Figure 3.5 (c). 
 




Figure 3.5: (a) 3D biventricular geometry of the rat heart reconstructed from CMR image data. (b) 
Biventricular cardiac geometry with local wall thickening (dotted circle) to account for the 
therapeutic myocardial hydrogel injectate. (c) Different views of the adjusted biventricular cardiac 
geometry combined with reconstructed hydrogel injectate geometry. The cardiac geometry is 
displayed partially translucent to for illustration purposes. 
3.4 Discussion 
A biventricular cardiac model of a rat heart was developed with a micro-structurally detailed 
geometry of a therapeutic PEG hydrogel injectate. This was achieved through combining 
histological analysis, CMR imaging and image-based geometrical reconstruction. The developed 
geometry of the PEG gel injectate captured the striated distribution of the hydrogel within the 
myocardium as observed in vivo in preclinical studies when the biomaterial was administered 
immediately after the infarction (Dobner et al. 2009; Ifkovits et al. 2010; Kadner et al. 2012). With 
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the simplified representation of the therapeutic myocardial injectates in previous computational 
studies, e.g. by homogenisation (Wall et al. 2006; Wenk et al. 2011b) and in coarse layers (Kortsmit 
et al. 2013), the injectate geometry reconstructed in the current study provides the basis for a more 
realistic implementation of intramyocardial injectates in computational models.  
Due to its micro-structural details, the injectate geometry is particularly suited for the investigation 
of micro-mechanical interactions between injectate and myocardial tissue. At this microscopic 
scale, the injectate model may also offer potential for studying the mechanobiology in MI cell 
therapies for which the injectate provides the physical environment of the injected cells. A 
macroscopic model of the injectate with less micro-structural details can be obtained from the 
existing geometry, e.g. to study global mechanics of the heart at reduced computational expense. 
As such, the models can facilitate multi-scale computational studies of injectate-based MI 
therapies.  
The infarcted rat heart from which the injectate model was developed was explanted minutes after 
infarct induction. Since geometrical changes were not expected in the cardiac wall during this short 
period of time, the geometry of the infarcted heart was assumed to be similar to that of a healthy 
heart. Accordingly, the biventricular cardiac geometry was developed from CMR image data 
obtained from a healthy rat. A local heart wall thickening (increase in wall volume) was assumed 
as a result of the additional injectate volume. Three-dimensional echocardiography-based models 
of sheep hearts demonstrated an increase in the heart wall thickness as a result of injecting 
hydroxyapatite-based tissue filler (Wenk et al. 2011b). For the PEG gel, it can be argued that 
the in vivo layered dispersion of the PEG gel will result in a volume change smaller than what was 
modelled in the current study. Nevertheless, local increase of the wall thickness at the epicardial 
and endocardial sides has been a common modelling procedure to account for the injectate volume 
(Kortsmit et al. 2013; Miller et al. 2013). 
For the development of computational models, e.g. for finite element analysis, cardiac and injectate 
geometries need to be complemented with additional structural and constitutive data. Such data 
can be obtained from literature, such as the distribution of myofibre alignment and constitutive 
properties of the rat heart (Omens et al. 1991), or experimentally. The gel model is generically valid 
to study the mechanics associated with injecting the gel immediately after the infarction induction 
since it has been shown that the gel could take a different in situ distribution when injected one 
week after the infarction (Kadner et al. 2012). Nevertheless, the approach of developing the model 
could be applied to obtain a realistic geometry of the injectate under different conditions, e.g. 
different injection timing.  
33 
 
4 Mechanical characterization of infarct 
tissue 
4.1 Introduction 
The functioning of a heart following a myocardial infarction (MI) is strongly influenced by the 
mechanics of the infarcted tissue. Understanding the passive mechanical properties of infarcted 
tissue at different infarct stages is essential for improving the emerging biomaterial injection 
treatments for MI. Additionally, capturing the mechanical properties of infarcted tissue allows the 
development of constitutive models for computational studies.  
The orientation of myocardial fibres causes the myocardial material to exhibit mechanical 
anisotropy (Bovendeerd et al. 1992). As such, uniaxial tensile testing is not sufficient in capturing 
the 3D constitutive behaviour of cardiac tissue even when applied individually in the principal 
material directions (Usyk and McCulloch 2003). Biaxial tensile testing has been commonly utilized 
in characterization of soft tissues; such as myocardium (Demer and Yin 1983), valve leaflets (Billiar 
and Sacks 2000; Grashow et al. 2006) and pericardium (Chew et al. 1986). 
Demer and Yin (1983) performed biaxial and uniaxial tensile tests on left ventricle (LV) tissue of 
canine hearts demonstrating the anisotropy, non-linear elasticity and viscoelasticity of the passive 
myocardium. Anisotropy was found to be regionally dependant in this study. Novak et al. (1994) 
observed similar anisotropy on different regions of LV and, however, different strain-energy levels 
when canine heart specimens were subjected to identical biaxial loading. Sacks and Chuong (1993a; 
1993b) investigated the biaxial mechanical properties of right ventricle (RV) and compared the 
results to those of LV. They concluded qualitative similarities and quantitative differences between 
the mechanics of right and left ventricles.  
One of the earliest attempt to investigate the biaxial mechanical properties of infarcted 
myocardium was presented by Gupta et al. (1994). They induced anterioapical MI in sheep hearts 
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by ligating the left anterior descending (LAD) and second diagonal coronary arteries. Hearts were 
harvested at 4 hours, 1, 2 and 6 weeks after coronary ligation and biaxial tensile load was applied 
along the cardiac circumferential and longitudinal directions. Gundiah et al. (2004) also studied the 
biaxial mechanical properties of healing MI in sheep hearts, however, they tested the infarcts at 2 
and 8 months following the infarction onset.  
Rats have been widely used as animal models in research of MI biomaterial injection therapy 
(Landa et al. 2008; Dobner et al. 2009; Kadner et al. 2012). Yet there is only one study in literature 
that quantifies the passive mechanical properties of infarcted myocardial tissue of a rat heart 
(Fomovsky and Holmes 2010). This emphasizes the need to conduct additional studies to establish 
and strengthen a baseline for assessing the mechanical properties of the infarcted tissue in the 
context of biomaterial injection treatment.  
Therefore, in this chapter the passive mechanical properties of the healing infarcts in rat hearts 
was investigated using multiple loading protocols. Anterioapical MI was experimentally induced 
through LAD coronary ligation. Infarct samples were obtained at different post-infarct time points 
and tested under planar biaxial tension and uniaxial compression respectively. In addition to 
improve the understanding of the mechanical behaviour of infarcted rat myocardium, this study 
aimed at providing sufficient data to develop material constants for infarcts at different healing 
stages.  
4.2 Materials and methods 
4.2.1 Myocardial infarction induction  
The animal experiments were approved by the Mississippi State University Institutional Review 
Board and Institutional Animal Care and Use Committee and were performed in accordance with 
the National Institutes of Health (NIH, Bethesda, MD, USA) guidelines. Surgical procedures were 
performed according to Huang et al. (2006). Male Wistar rats (215-280g) were anaesthetized with 
a mixture of oxygen and 5.0% Isoflurane and intubated with a 16G intravenous catheter. Body 
temperature was maintained by placing rats on a heated operating pad. Positive-pressure 
ventilation was established and anaesthesia was maintained with a mix of oxygen/2.0% Isoflurane. 
A left thoracotomy was performed at the 4th intercostal space and ribs were retracted followed by 
a pericardiotomy. MI was induced by permanent ligation of LAD coronary artery with a 6-0 silk 
ligature 2-3 mm distal to the auricular appendix. The effectiveness of MI induction was assessed 
by the extent of paleness and fibrillation (uncoordinated contraction) of the myocardial tissue on 
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the anterior ventricular wall. Animals were euthanized by arresting the heart via intracardiac 
injection of saturated potassium chloride solution and hearts were harvested and fixed in 10% 
phosphate buffered saline (PBS).  
Infarcted hearts were harvested immediately (0 day), 7, 14 and 28 days after infarct induction (n= 5, 
9, 9 and 9 respectively) representing several healing stages. For the animals of 7d, 14d and 28d 
groups, the chest was orderly closed and the animal was given subcutaneous buprenorphine 
injection for postoperative pain management.  
4.2.2 Heart dissection and testing sample preparation 
The harvested hearts were dissected to prepare testing samples. The atria, pulmonary trunk and 
the free wall of the right ventricle were cut away. A longitudinal cut was made through the posterior 
wall of the LV from the base to apex. The LV was unfolded and a full transmural square sample 
(~10×10 mm) was dissected from the anterioapical region of the LV wall. All mechanical tests 
were carried out within 7 hours after harvesting the hearts. Samples were always kept moisturized 
during manipulation by continuously applying 10% PBS. 
4.2.3 Biaxial tensile test 
The biaxial mechanical properties of myocardial tissue samples were captured using a biaxial 
testing system (Grashow et al. 2006) shown in Figure 4.1 (a). The length, width and thickness of 
samples were measured using a Vernier calliper and recorded prior to testing. For a single sample, 
3 thickness measurements were made and the average was taken. Four optical markers were glued 
to the epicardial surface of the sample marking a ~ 4×4 mm area in the centre. Two evenly spaced 
suture needles were placed on each side of the sample ~2 mm away from the edge, Figure 4.1 (b 








Figure 4.1: (a) Biaxial testing rig. (b) Tissue sample with four optical markers glued to the epicardial 
surface. Eight suture needles were placed in the sample. (c) Tissue sample mounted in the biaxial 
during testing. 
All biaxial tests were performed with tissue samples completely submerged in 37°c 10% PBS. 
Biaxial tensile load was applied along the cardiac circumferential and longitudinal directions of the 
sample at 0.5 mm/s.  Following 10 preconditioning cycles of 30 N/m (force per unit length of the 
sample) equibiaxial tension, three loading protocols were applied (circumferential:longitudinal 
N/m) as illustrated in Figure 4.2: 
 Equibiaxial tension: 60:60 N/m (Protocol 1). 
 Non-equibiaxial tension: 30:60 N/m (Protocol 2). 
 Non-equibiaxial tension: 60:30 N/m (Protocol 3). 
 
 
Figure 4.2: Biaxial loading protocols applied for testing of infarct samples. 
Mean stress-strain graphs in the circumferential and longitudinal directions were presented for 
different infarct groups. To quantify the tensile stiffness in the two material axes, circumferential 
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sample. This was achieved by calculating the maximum slope of the stress-strain curve at the region 
bounded by 15 and 20 kPa of stress.  
The non-equibiaxial loadings (i.e. Protocol 2 and 3) were introduced to examine the in-plane 
mechanical coupling between the circumferential and longitudinal axes and to provide the 
sufficient amount of data for the constitutive modelling. The mechanical coupling was examined 
by assessing the effect of increasing the tension in one axis on the extensibility of the other axis 
(Billiar and Sacks 2000; Ghaemi et al. 2009).  
4.2.4 Uniaxial compression test 
Following the biaxial test, tissue samples underwent transmural compression testing, up to 30% 
of the sample thickness, using a uniaxial testing System (Mach-1, Biosyntech, MN, USA). Samples 
were secured in place using a small amount of cyanoacrylate ester adhesive. The compression was 
applied at the 4 locations of optical markers using a plate indenter of ~2.7 mm diameter while 
sample submerged in 10% PBS as illustrated in Figure 4.3. As such, 4 compression measurements 
were obtained from a single sample.  Each marker spot was preloaded to 2 g, preconditioned for 
10 cycles of 5% compression and then loaded to 30% compression. Compression load was applied 
at rate of 
𝑇
10
 mm/s, where 𝑇 is the sample thickness. This is equivalent to strain rate of 0.1/s. 
Compressive stress-strain data was obtained for the different infarct groups. The compressive 
moduli were calculated from the slope of the stress-strain curve at the region bounded by 25% 
and 30% of compressive strain. 
 
Figure 4.3: Compression test of infarcted tissue samples. 




Following mechanical testing, the infarcted tissue samples of the 7, 14 and 28 day groups were 
fixed in 4% paraformaldehyde for 48 hours and then in 70% ethanol. Histology analysis was 
performed to confirm and quantify the infarction in each sample. 
The freehand diagram in Figure 4.4 illustrates sample dissection and marking for histology analysis. 
The tissue portion above the ligation site was cut away since it has no significance in the infarct 
analysis. The sample was then cut into 4 equal circumferentially-adjacent blocks differentiated with 
different colours on the lateral surface so that section were obtained from the medial surface. The 
blocks were processed through graded alcohols (Illovo Sugar Ltd., Durban, South Africa) xylene 
(Saarchem, Gauteng, South Africa) and infiltrated with paraffin wax using the Tissue-Tek Rotary 
Tissue Processor (Sakura Finetek, Tokyo, Japan). After that, tissue blocks were embedded in 
paraffin wax  (Merck KGaA, Darmstadt, Germany) and 2 sections of 4 µm were cut from the 
medial surface of each block , i.e. 8 sections per sample, at 0 and 120 µm using a Rotary Microtome 
HM360 ( Microm, Waldorf,Germany).  Sections were picked up on glass slides (Marienfeld GmbH 
& Co. KG, Lauda-Königshofen, Germany) and baked on a hot plate at 60 °C (Kunz Instruments 
AB, Nynäshamn, Sweden)  for 30 minutes before being dewaxed in xylene and hydrated through 
graded alcohols down to water. 
 
Figure 4.4: Schematic of tissue sample dissection and marking. 
Tissue sections were then stained using Masson’s trichrome to distinguish the collagen fibres from 
myocytes in the tissue. A 0.5% Acid Fuchsin solution (Merck KGaA, Darmstadt, Germany) was 
applied for 5min and rinsed in tap water. Excess Acid Fuchsin was removed by applying 1% 
Phosphomolybdic acid solution (SigmaeAldrich Chemie GmbH, Steinheim, Germany) for 5min. 
The slides were then washed in water and counterstained  for 2 min with 2% Light Green SF 
Yellowish (Sigma Aldrich Chemie GmbH, Steinheim, Germany) before they were dehydrated 
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through alcohol, cleared with xylene and mounted with Entellan (Merck KGaA, Darmstadt, 
Germany). 
4.2.6 Infarct quantification 
Images of histology sections were acquired using Eclipse 90i microscope with DXM-1200C digital 
camera (Nikon Corporation, Tokyo, Japan) at 2 × magnification and stitched (NIS Elements BR 
3.0, Nikon Corporation). Digital images of tissue sections were imported in Visiopharm Integrator 
System (Visiopharm, Hørsholm, Denmark) for analysis. The infarct and intact areas, characterized 
by the presence of collagen and cardiomyocyte respectively as demonstrated in Figure 4.6 (a), were 
measured in each section using an unsupervised image analysis in which infarct and intact regions 
were segmented using coloured masks, Figure 4.6 (b). The percentages of the infarct and intact 
areas in the individual sections were calculated. The overall infarct size of a sample was estimated 
by normalizing the sum of infarct areas in the 8 sections by the sum of the entire section areas. 
Samples that exhibited less than 40% infarction were excluded from the study (will be discussed 
later). 
4.2.7 Statistical analysis 
The experimental data were presented as mean ± standard deviation (SD). The statistical analysis 
was performed using one-way analysis of variances (ANOVA) followed by Fisher least square 
deviation (LSD) multiple comparison post-hoc test between groups (STATISTICA 12, StatSoft, 
Inc., Tulsa, USA). The differences were considered statistically significant when p<0.05.  
4.3 Results 
4.3.1 Visual inspection of harvested hearts 
By visual inspection of the harvested hearts, the 0d infarct hearts did not show noticeable changes 
and thus distinguishing the infarct zone was not applicable. However, the infarct zone was clearly 
visible on the hearts of 7, 14 and 28d groups as shown in Figure 4.5. The infarct zone extended 
distal to the ligation site. The damaged tissue appeared in a pale colour which was distinguishable 
from the red/brown colour of the surrounding intact myocardium. A loss in the muscle tone and 
wall thinning were also remarkable characteristics of the infarcted tissue in contrast to the intact 
myocardium.  




Figure 4.5: Harvested infarcted hearts at 7 (a), 14 (b) and 28 days (c) after coronary artery ligation 
showing the infarcted tissue (dotted circle) and locations of ligating sutures (arrow). 
4.3.2 Histology-based infarct size estimation 
Staining the tissue sections of the infarcted samples with Masson’s trichrome distinguished the 
collagen fibres from myocytes. The collagen appeared blue while myocytes appeared red as 
illustrated in Figure 4.6 (a). As a result of segmentation in Visiopharm, Figure 4.6 (b), the collagen 
and myocytes were covered with blue and green masks, respectively. As such, the area of these 
masks represented the areas of the infarct and intact tissue in a section. Holes and gaps in the 
tissue (background) were masked using grey colour and were not included in the analysis. 
The histogram in Figure 4.7 shows a quantification of infarct in the individual sections of samples 
for different groups. The infarcted area was presented as percentage of the entire section area. For 
illustration purposes, the samples in each group were numbered from 1 to 9 while sections were 
numbered from 1 to 8. Some samples were fully intact, i.e. without any infarcted tissue, indicating 
an unsuccessful MI induction, e.g. Sample 2 at 7d, Sample 7 at 14d and Sample 1 at 28d. No sample 
showed infarction in all of the 8 sections; the maximum was 7 sections. The estimated infarct size 
in samples is shown in Figure 4.8. The overall average infarct size for the 7d, 14d and 28d infarct 
groups was found to be 50%, 49% and 53%, respectively. 




Figure 4.6: (a) Histological micrograph of an infarcted tissue section stained with Masson’s 
trichrome. Collagen appears blue and myocytes appears red. (b) Image after being segmented in 








Figure 4.8: Estimated infarct size in tissue samples of 7, 14 and 28 day infarct groups. 
4.3.3 Equibiaxial tension 
The biaxial testing of some samples failed due to technical issues producing incomplete mechanical 
data. These samples were excluded from the study. Table 4.1 summarizes the final number of 
samples from each infarct group for all protocols of biaxial testing.  
Table 4.1: Total number (n) of samples that underwent biaxial testing. 
Infarct group 0d 7d 14d 28d 
n 5 5 3 4 
 
The stress-strain relationship of the equibiaxial test for different infarct groups is shown in 
Figure 4.9. In general, all infarct groups exhibited an anisotropic nonlinear behaviour in which the 
circumferential direction was stiffer than the longitudinal direction. However, a significant 
difference was observed between the maximum circumferential and longitudinal strains (i.e. at 
20 kPa of stress) in the 0d, 14d and 28d infarct groups (p=0.0098, 0.0056 and 0.045 respectively). 
The 0 and 7d groups, Figure 4.9 (a) and (b) respectively, showed an isotropic behaviour at lower 
strain (up to ~0.07 for 0d and ~0.05 for 7d). The anisotropy in the 14d infarct group, Figure 4.9 
(c), was more pronounced than in other groups. 




Figure 4.9: Mean stress-strain relationship from the 60:60 N/m biaxial test for 0 (a), 7 (b), 14 (c) 
and 28 day (d) infarct group. Error bars represent SD and were partially presented for illustration 
purposes. * p<0.05. 
The tensile modulus, shown in in Figure 4.10, was calculated for the different infarct groups as an 
indication for infarct stiffness. In the circumferential direction, Figure 4.10 (a), the moduli for 0d, 
7d, 14d and 28d groups was found to be 443, 670, 857 and 1218 kPa, respectively. The stiffness 
increased in proportion to the increasing time after coronary ligation. The modulus of the 28d 
infarct was significantly higher compared to the 0d (p=0.0098) and 7d (p=0.048) infarcts. In the 
longitudinal direction, Figure 4.10 (b), the infarcts at 0, 7 and 14 days exhibited moduli of 247, 250 
and 212 kPa, respectively. At 28 day an increase in the stiffness was observed (487 kPa), yet 
insignificant.  
 





Figure 4.10: Mean circumferential (a) and longitudinal (b) tensile modulus calculated for different 
infarct groups. Error bars represent SD. * p<0.05. 
4.3.4 Non-equibiaxial tension 
The stress-strain relationship of the 30:60 biaxial test for different infarct groups is shown in 
Figure 4.11. All infarct groups exhibited negative circumferential strain due to the in-plane 
mechanical coupling between the two axes. The variation in the circumferential extensibility 
between infarct groups was very limited compared to the longitudinal extensibility. The stress-
strain graphs from the 60:30 loading protocol are shown in Figure 4.12. Negative longitudinal 
























































Figure 4.11: Mean stress-strain relationship from 30:60 N/m biaxial test for 0 (a), 7 (b), 14 (c) and 
28 day (d) infarct group. 
 
 
Figure 4.12: Mean stress-strain relationship from 60:30 N/m biaxial test for 0 (a), 7 (b), 14 (c) and 
28 day (d) infarct group. 




Figure 4.13: Peak circumferential (a) and longitudinal (b) strain obtained from different loading 
protocols demonstrating the effect of mechanical coupling. The percentage change in strain 
between loading protocols is indicated for each infarct group.  Data are presented in mean and 
error bars represent SD.  
The in-plane mechanical coupling between the circumferential and longitudinal direction of 
infarcts was assessed by comparing the change in extensibility in one direction as the load increases 
in the other direction. Figure 4.13 illustrates the change in peak strain in one direction as the 
tension changes in the other direction. For example, the 7d infarct exhibited 23% decrease in the 
circumferential strain when the longitudinal tension was increased from 30 (in the 60:30 protocol) 
to 60 N/m (in the 60:60 protocol) as shown in Figure 4.13 (a). However, the longitudinal strain of 
the same group decreased by 36% when the circumferential tension was increased from 30 (in the 
30:60 protocol) to 60 N/m (in the 60:60 protocol). The mechanical coupling in 0 and 14d groups 
was nearly symmetric, i.e. equal change in directional strain, whereas asymmetric mechanical 
coupling was observed for 7 and 28d groups. The strongest mechanical coupling (40%) was 
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longitudinal strain. This indicates that the longitudinal axis had a stronger mechanical effect on the 
circumferential axis in the 28d infarct.  
4.3.5 Compression  
Erratic compression measurements from some samples were excluded from the study. Several 
compression measurements were obtained from a single sample. Table 4.2 illustrates the total 
number of measurements obtained for each infarct group. 
Table 4.2: Total number (n) of compression measurements obtained for different infarct groups. 
Infarct group 0d 7d 14d 28d 
n 5 6 8 6 
 
Figure 4.14 illustrates the compressive mechanical properties of the infarcted myocardium. All 
infarct groups exhibited a non-linear compressive stress-strain behaviour as shown in 
Figure 4.14 (a). Up to 10% of compressive strain, a similar linear stress-strain behaviour was 
observed. Variation between groups became more pronounce as the strain exceeded 20%. 
The compressive moduli, shown in Figure 4.14 (b), was found to be 145, 242, 247 and 522 kPa for 
0d, 7d, 14d and 28d infarct groups. The 28d infarct group showed a significantly higher 
compressive modulus compared to other infarct groups (p= 0.0055, 0.028, and 0.018 for 0, 7 and 
14d groups respectively). 




Figure 4.14: Compressive mechanical properties of infarcted myocardium. (a) Mean compressive 
stress-strain relationship for different infarct groups. (b) Mean compressive modulus calculated 
for different infarct groups. Error bars represent SD. * p<0.05. 
4.4 Discussion 
This study investigated the mechanical behaviour of rat infarcted myocardium under different 
loading conditions taking into account the temporal change in mechanical properties of healing 
infarcts. The infarcted hearts were explanted immediately, 7, 14 and 28 days after LAD coronary 
artery ligation. Infarct samples underwent planar equibiaxial and non-equibiaxial tensile tests 
followed by wall compression test. Infarcts maintained anisotropy and the nonlinear biaxial and 
compressive mechanical behaviour throughout the healing phases. At low strain range, infarcts 
could exhibit isotropy during the first week after the infarct onset. Mechanical coupling was 
observed between the two axes in all infarct groups. Infarcts were stiffer in the circumferential 
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circumferential and compressive stiffness was more significant than the increase in longitudinal 
stiffness. 
4.4.1 Induction of myocardial infarction 
In vivo MI induction in rats is a challenging procedure due to some commonly known factors. 
These include the small size of a rat heart, the small exposure site and the difficulty in maintaining 
a consistent infarct size. The latter is a crucial factor when aiming at mechanically testing the 
infarct. Ideally, the testing sample should be 100% infarcted to precisely capture the mechanical 
properties of the infarct. 
In the current experiments, the aim was to induce as large infarcts as possible. One way to achieve 
this was by using multiple ligation sites (Figure 4.5 (a)) instead of a single site. Another utilized 
technique was to increase the size of the occluded region as proposed by Huang et al. (2006). Yet 
no samples from the 7, 14 or 28 day groups was 100% infarcted. Furthermore, MI induction was 
completely unsuccessful in some samples yielding 0% infarct size (Figure 4.8) and produced 
relatively small infarct sizes such as 4, 9 and 12% in other samples. This highlights the difficulty to 
control the infarct size or maintain its consistency among infarct groups. 
4.4.2 Area-based quantification of infarcts 
The histology analysis was performed following mechanical testing to examine the consistency of 
the induced infarcts. In order to provide an adequate estimate of the infarcted wall in a sample, 
histology-based measurement of the infarcted area was applied in 8 equidistant parallel sections of 
the testing sample.  
MI studies that involve experimental infarcts in rodent models usually followed two common 
histology-based approaches to estimate the infarct size in the LV: (1) measuring the area of the 
infarcted region  (Piot et al. 1997; Liu et al. 2002; Park et al. 2004) or (2) measuring the arc length 
of the infarcted region (Pfeffer et al. 1979; Kadner et al. 2012). The area-based method is often 
used with early stage infarcts. However, the wall thinning associated with the late stage infarcts 
makes the length-based method more suitable (Takagawa et al. 2007).  
Although the current experiments involved chronic infarcts, the area-based method was utilized. 
Unlike other studies in which infarct size was measured in the entire LV, the infarct size in this 
study was measured in the sample only. The sample represented a small portion of the LV where 
the infarct would most likely lie. As such, even though a sample experienced wall thinning, the 
thickness was uniform in the whole sample. Furthermore, the area-based method was more 
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accurate and limited the subjectivity. Applying this method at 8 equally spaced sections provided 
an adequate estimate of the infarct size on a sample. 
4.4.3 Infarct size threshold  
Following the histological analysis of infarct samples, an infarct size threshold of 40% was 
determined. A sample of infarct size below 40% was considered poorly infarcted and excluded 
from the study. The motivation for obtaining this threshold originated from the fact that no sample 
from the chronic infarct groups (i.e. 7, 14 and 28 day) was 100% infarcted (Figure 4.8). As such, it 
was necessary to ensure that the entire central target region of the biaxial testing samples (Sacks 
2000) contained as much properly infarcted tissue as possible.  
The histogram of the infarcted area in individual sections (Figure 4.7) provides information on the 
distribution of the infarct both circumferentially and longitudinally. All samples were cut at the 
ligation site prior to histology analysis. Therefore, a single bar in the histogram demonstrates how 
far the infarct in that particular section extends in the longitudinal direction. The 8 bars of a sample 
represent equally spaced longitudinal sections and thus together illustrate how far the infarct 
extends circumferentially. Examining the histology images and the in-plane extension of the 
infarct, 40% was found to be the minimum infarct size required to ensure a transmural and 
adequate circumferential and longitudinal extend of the infarct.  
By eliminating samples that exhibited less than 40%, the chance that the mechanical properties 
were captured from properly infarcted target region was considerably increased. This was also 
confirmed for the compression data since compressive loads were applied at the optical markers 
which were located in the target region. It is important, however, to note that the 40% value was 
obtained based on the analysis of the sets of infarcted hearts presented in this study and is not 
necessary suitable for other studies.  
4.4.4 Infarct quantification in the immediate infarct group 
The infarct size in the immediate (i.e. 0d) group was not quantified in this study. Collagen starts 
accumulating in infarcted tissue at 2 days after infarction onset (Cleutjens et al. 1999). Therefore, 
Masson’s trichrome staining was not suitable for this group since the infarcted hearts were 
harvested few minutes after coronary ligation. Triphenyltetrazolium chloride (TTC) staining is a 
macroscopic approach widely used to identify early phase post-mortem infarcted myocardial tissue 
(Fishbein et al. 1981; Khalil et al. 2006). In a pilot study on the 0d infarcts, TTC staining did not 
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identify the infarcts after biaxial testing although successfully did so on samples that did not 
undergo biaxial testing. The major causes of this observation are not yet fully understood.  
Nevertheless, all hearts from the 0d group were assumed to be properly infarcted and thus included 
in the study. This assumption was based on a key argument. Since the heart was to be harvested 
immediately, a lengthy thoracotomy was made during operation and the heart was openly exposed 
allowing comfortable access to the LAD coronary artery. As such, the MI in this group was induced 
with high certainty providing a consistent mechanical properties as illustrated by the relatively small 
standard deviation in this group (Figure 4.9 (a)). 
4.4.5 Mechanical properties of infarcts 
Our study showed that infarcts maintain the non-linear anisotropic mechanical behaviour 
throughout the different healing stages with varying degree of anisotropy (Figure 4.9). However, 
during the first 7 days after coronary ligation, infarcts showed an isotropic behaviour under low 
strain. Anisotropic behaviour of the infarcted tissue under equibiaxial tension was also observed 
in previous studies on sheep models (Gupta et al. 1994; Gundiah et al. 2004). One exception was 
the study by Fomovsky and Holmes (2010) who suggested that healing rat infarcts were isotropic.  
These studies and others (Cleutjens et al. 1995; Fomovsky et al. 2010) demonstrate that collagen 
is the major determinant of the mechanical properties of the infarcted myocardium. In particular, 
the degree of anisotropy is primarily determined by the alignment of the collagen fibres although 
isolated muscle fibres may have an effect (Gupta et al. 1994). A previous study on rat infarcts 
(Fomovsky et al. 2012) showed that the alignment of collagen fibres varies with the location in the 
LV as illustrated in the histograms in Figure 4.15. For example, collagen in a mid-ventricle infarct 
was aligned mostly in the circumferential direction (0°) while collagen fibres were randomly 
oriented in an apical infarct. As such, the discrepancy between the findings of the current and 
Fomovsky’s studies with regard to categorizing the mechanical behaviour of the infarct can be 
attributed to the different location of the examined infarcts. Highly oriented collagen fibres, 
observed in a mid-ventricle infarct, induces anisotropy while a random collagen orientation, 
observed in an apical infarct, will yield an isotropic behaviour. In the current study, the infarct 
samples contained a considerable portion of the anterior wall of the LV. Therefore, they showed 
mechanical anisotropy with the circumferential direction being stiffer than the longitudinal due to 
the circumferentially oriented collagen.  




Figure 4.15: Histograms of collagen content and orientation in rat infarcts at 3 weeks after 
infarction. (a) Infarct located at the mid-ventricle region. (b) Apical infarct. (modified from 
Fomovsky et al. (2012)) 
The orientation of collagen and the degree of cross-linking is believed to play a major role in the 
mechanical coupling (Figure 4.13) observed between material axes when infarcts are subjected to 
non-equibiaxial tension. Mechanical coupling has been reported for several biological soft tissues 
such as; myocardium (Yin et al. 1987; Ghaemi et al. 2009), pericardium (Sacks and Chuong 1998), 
valve leaflet (Billiar and Sacks 2000) and urinary bladder (Gilbert et al. 2008). The exact underlying 
mechanism which causes this phenomena is not clear although some hypothesis attributed it to 
the dynamic change of collagen orientation in response to the unequal biaxial loading (Yin et al. 
1986; Billiar and Sacks 2000). Nevertheless, the non-equibiaxial experiment presented in this study 
provides the data required to identify material parameters for different infarcts. 
 
Figure 4.16: Histograms of collagen content and orientation in infarcts from rat and pig models at 
different time points after infarction. (modified from Fomovsky and Holmes (2010)) 
The increase in the circumferential (Figure 4.10 (a)) and compressive (Figure 4.14) stiffness of the 
healing infarcts with time is attributed to the accompanying increase in collagen deposition and 
cross-linking (Vivaldi et al. 1987; Cleutjens et al. 1995). While the compressive stiffness is related 
to the content of collagen, the directional stiffness is predominantly controlled by the orientation 
of the deposited collagen. For example, the change in the longitudinal stiffness (Figure 4.10 (b)) 
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with increasing healing time, though not statistically significant, could be attributed to the 
circumferential orientation of the accumulated collagen. These arguments agree with the findings 
from a previous study (Fomovsky and Holmes 2010) as shown in the histogram Figure 4.16. The 
histogram shows the collagen content and orientation in rat infarcts at 1 and 6 weeks after 
infarction. The increase in collagen content at 6 weeks compared to 1 week is noticeable. However, 
the increase in the content of the longitudinal collagen is very small compared to that of the 
circumferential collagen. In the current study, the circumferential stiffness of the infarct at 28 days 
was significantly higher compared to 7 days, whereas the difference in longitudinal stiffness 
between 7 and 28 days was not statistically significant.  
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5 Identification of material model 
parameters of infarct tissue 
5.1 Introduction 
Computational biomechanics has been effectively utilized for disease investigation and therapy 
optimisation providing answers to many clinical questions. In the cardiovascular area, finite 
element (FE) models have been established for studying the mechanical aspects of myocardial 
infarction (MI) (Wenk et al. 2011a) and its emerging intramyocardial injection treatment (Kortsmit 
et al. 2013; Miller et al. 2013).  
The passive constitutive behaviour of myocardium has been modelled as transverse-isotropic 
(Humphrey et al. 1990b; Guccione et al. 1991) or orthotropic (Costa et al. 2001; Holzapfel and 
Ogden 2009) incompressible finite elastic material using hyperelastic pseudo-strain energy 
functions. Inverse methods are utilized for estimating the parameters of these constitutive models 
by fitting FE models solution to experimental data. Such experimental data are obtained either 
from mechanical testing of isolated heart samples, e.g. stress-strain relationship from biaxial 
testing, or by measuring regional deformation from the whole heart in vivo or in vitro, e.g. local 
myocardial strain using ultrasound imaging, (Usyk and McCulloch 2003). 
Omens et al.(1993) inflated a left ventricle of an isolated rat heart using balloon and measured the 
two-dimensional strain. FE model was developed to optimise the parameters of a transversely 
isotropic strain energy function by fitting solutions to the measured experimental strain. Gupta et 
al. (1994) utilized orthotropic model to fit biaxial data of sheep infarcted myocardium.  Fomovsky 
and Holmes (2010) used the least-squares method to fit isotropic constitutive model to biaxial 
stress-strain data of infarcted rat heart. Lee et al. (2011) developed a FE model of an infarcted left 
ventricle of a sheep heart. They optimised active parameters in a transversely isotropic material 
model to fit in vivo end-systolic strains and cavity volume measured from tagged magnetic 
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resonance images (MRI). A similar approach was used by Wenk et al. (2012), however, passive and 
active parameters of the material model were optimized by fitting FE solutions to patient-specific 
measurements from tagged MRI. 
Genetic algorithm (GA) is a global search method based on the concept of biological evolution. 
Treating sets of solutions in optimization problems as “chromosomes”, GA applies genetic 
operations, such as crossover and mutation, to form an improved chromosomes in the newly 
developed generations. GA has been employed for problem optimization in the medical field. 
Wang et al. (2006) used GA to optimise parameters of Fung strain energy function for pig coronary 
arteries. GA were combined with FE modelling and employed in elasticity reconstruction of 
atherosclerotic arterial plaque (Khalil et al. 2006). GA and FE modelling were also utilized by 
Yeoman et al. (2009) and Kichula et al. (2014) to optimize material parameters for vascular graft 
and myocardial tissue, respectively.  
In this chapter, the aim was to identify the parameters of an orthotropic constitutive model for 
the different healing stages of rat heart infarcts utilizing the biaxial mechanical data presented in 
Chapter 4. A biaxial tension FE model was developed mimicking the setup of the experimental 
biaxial test. The model underwent verification tests to optimize the model attributes. GA was 
employed to minimize the error between the predicted and experimental data.  
5.2 Materials and methods 
5.2.1 Biaxial tension finite element model  
Abaqus CAE 6.12-2 (Dassault Systèmes, Providence, RI, USA) was employed to build and run the 
biaxial tension FE model. A three-dimensional (3D) model of the tissue sample was generated by 
extruding a square area of length (l) by depth (𝑇) as illustrated in Figure 5.1. The endocardial and 
epicardial surfaces were represented by 𝑥-𝑦 planes at 𝑧=0 and 𝑧= 𝑇 respectively. As a result, the 
𝑥 and 𝑦 axes of the model represented the circumferential and longitudinal axes respectively. The 
eight suture needles (C1 to C8) used in the experiment were modelled using cylindrical transmural 
partitions of 0.4 mm diameter (the physical diameter of the needles). The two adjacent cylinders 
on each side were separated by l/3 while all cylinders were positioned 2 mm away from the edge. 
Four reference points (RP1 to RP4) were defined at the central area of the epicardial surface of 
the model representing the four optical markers used in the experiment. A tie constraint was 
defined to couple the movement of the four reference points (slave) to the local movement of the 
epicardial surface (master).  





Figure 5.1: (a) Two-dimensional sketch of the FE model showing the positions of suture needles 
(C1-8) and reference points (RP1-4). (b) Extruded geometry of the specimen showing epicardial 
and endocardial surfaces.  
Four models were developed representing the four infarct groups, i.e. immediate (0 day), 7, 14 and 
28 days. The models were assigned the mean length (l) and thickness (T) measured from individual 
samples in each infarct group. Table 5.1 shows the dimensions assigned to the four models.  
Table 5.1: The dimensions of the biaxial tension model for different infarct groups.  
Model l [mm] T [mm] 
0 day infarct (0d) 12.09 3.04 
7 day infarct (7d) 11.72 2.42 
14 day infarct (14d) 11.81 3.07 
28 day infarct (28d) 11.41 1.80 
 
The model was discretized using linear hexahedral reduced-integration hybrid elements 
(C3D8RH). The mesh contained 1896 elements. The orientation of myocardial fibres was 
incorporated in the model by a user-defined material orientation (ORIENT) subroutine. 
The subroutine was utilized to define fibre orientation in the specimen model through 14 
transmural layers of fibre angles. The fibre angles ranged linearly from -50° at the epicardial layer 
to 80° at the endocardial layer (Chen et al. 2003).  
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The mesh density, element type and number of transmural layers of fibres were determined from 
a series of verification tests as will be discussed later in detail. 
5.2.2 Boundary and loading conditions 
Displacement boundary conditions were applied to the cylinders to restrain the model (C1 to C4) 
and to apply the tensile loads (C5 to C8) as illustrated in Figure 5.2. The translational movement 
of C1 and C2 was constrained in the 𝑦-axis while the translational movement of C3 and C4 was 
constrained in the 𝑥-axis. All cylinders were allowed to rotate freely. Circumferential tensile load 
was applied by displacing C7 and C8 in the 𝑥-axis while longitudinal tensile load was applied by 
displacing C5 and C6 in the 𝑦-axis. 
 
Figure 5.2: Illustration of the boundary conditions defined in the model.  
5.2.3 Constitutive model 
From a number of anisotropic hyperelastic constitutive models available in Abaqus, the orthotropic case of 
the generalized Fung model was utilized to model the material properties of the infarct. The generalized 
Fung strain energy potential is based on the exponential form suggested by Fung et al. (1979) 
appropriately generalized to arbitrary 3D states following Humphrey (1995). The generalized Fung 
strain energy function (𝑊) has the following form (Abaqus 2012):  
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 𝑊 = 
𝑐
2
(𝑒𝑄 − 1)  5-1 
 where 𝑐 is the stress scaling factor and 𝑄 is given by 
 𝑄 = 𝜀̅𝐺: 𝑏 ∶  𝜀 ̅𝐺 = 𝜀?̅?𝑗
𝐺𝑏𝑖𝑗𝑘𝑙𝜀?̅?𝑙
𝐺  5-2 
where 𝑏𝑖𝑗𝑘𝑙 is a dimensionless symmetric fourth-order tensor of anisotropic material parameters and 
𝜀?̅?𝑗
𝐺  and 𝜀?̅?𝑙
𝐺  are the modified Green strain tensor. For the orthotropic case of the generalized Fung 
model, 9 material parameters must be specified.  
As explained by Sun and Sacks (2005), in the unloaded configuration matrix 𝐷should be positive 
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The positive definiteness implies the following parameter constraints: 
 Constraint 1:           
 
𝑏1111 𝑏2222 − 𝑏1122
2 > 0, 
 
5-4 
 Constraint 2:   
(𝑏1111𝑏2222 − 𝑏1122
2 )𝑏3333 − 𝑏1111𝑏2233
2 + 2𝑏1122𝑏2233𝑏1133 − 𝑏2222𝑏1133
2 > 0  5-5 
 Constraint 3 to Constraint 9:   
𝑐 > 0,   𝑏1111 > 0,   𝑏2222 > 0,   𝑏3333 > 0,   𝑏1212 > 0,   𝑏1313 > 0,   𝑏2323 > 0 5-6 
These constraints were applied during the optimisation process of the material parameters, as will 
be described in the following section.  
5.2.4 Optimization of material parameters 
The aim was to optimize the material parameters of Fung-orthotropic model to fit the FE model 
solution to the experimental stress-strain data for up to 5% of biaxial strain; the average 
physiological range of infarct deformation (Fomovsky and Holmes 2010).  Displacement-
controlled FE simulations were run and the computed stress data were compared to the 
experimental data. The objective function (OBJ) utilized in the optimization was developed so that 
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it returns the mean absolute percentage error (MAPE). The GA toolbox in SCILAB 5.4 (Scilab 
Enterprises S.A.S, Versailles, France) was utilized to minimize the objective function. For each 
infarct model, the FE stress data were obtained from three simulations: M6060, M3060 and 
M6030, representing the three biaxial testing protocols of equibiaxial and non-equibiaxial loading 
described in Chapter 4; 60:60, 30:60 and 60:30 N/m. These simulations were displacement-
controlled wherein the driving longitudinal and circumferential displacements were determined 
from the experimental strains. 
The objective function is given by: 










where 𝑆𝑒𝑥𝑝 and 𝑆𝑐𝑚𝑝 are the experimental and computational stresses, respectively, 𝑡 denotes the 
data point and 𝑛 is the total number of fitted data points. In the optimization process, 𝑛 = 32 
data points were utilized; 6 equidistant points in each direction from three loading protocols. 
Upper and lower bounds were set for the material parameters as illustrated in Table 5.2. These 
bounds enforced the constraints described in Eq. 5-6, i.e. Constraint 3 to 9. 
Table 5.2: Bounds of material parameters applied in the optimization process. 
Material parameter Lower Upper 
𝑏1111 0.01 200 
𝑏1122 -100 100 
𝑏2222 0.01 200 
𝑏1133 -100 100 
𝑏2233 -100 100 
𝑏3333 0.01 200 
𝑏1212 0.01 200 
𝑏1313 0.01 200 
𝑏2323 0.01 200 
𝑐 (kPa) 0.02 5 
 
The flow chart of the optimization loops is shown in Figure 5.3. Initially, several sets of 
parameters (population) were defined. The set (member) contained an array of 10 values 
representing the material parameters. The member then underwent a series of tests to evaluate 
the violation of Constraint 1 (Eq.  
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5-4) and Constraint 2 (Eq. 5-5). If a violation was detected, the member was penalized by assigning 
an OBJ value according to the severity of the violation. Otherwise, the parameters values would 








At completion of FE simulations, computational and experimental stresses were compared and 
the OBJ value was calculated. After that, the member was ranked in such a way that the lower the 
OBJ value was, the higher the rank would be. The next member in the population underwent the 
same process until all members were assigned OBJ value and ranked. Then, a new generation was 
formed. This was accomplished by subjecting the highly ranked members to crossover and 
mutation processes to generate new members. Crossover is the exchange of parameter values of 
two members (couple), while mutations are changes to a parameters value in a member (Yeoman 
2004). The members of the new generation were ranked and a third generation was formed. The 
loop continued until the predefined number of generations was reached at which a list of the 
OBJ-ranked members was returned. The member with the smallest OBJ demonstrated the best 
fit. The GA predefined parameters were set as follows: 
 Population size = 100; the number of members in a single generation (iteration). 
 Number of generations = 10; equivalent to the number of iterations in the traditional 
optimization methods. 
 Mutation probability = 0.5. 
 Crossover probability = 0.7. 
  Number of couples = 50; the number of member pairs (parents) in a population from 
which new members are formed through mutation and crossover. 
5.2.5 Computation of stress and strain 
The biaxial stress and strain were computed in SCILAB environment. Python script was utilized 
to extract the required results from the model output-database file.  









where 𝑆𝑥𝑥, 𝑓𝑥 and 𝑆𝑦𝑦, 𝑓𝑦 are stress and force in the circumferential and longitudinal directions 
respectively, 𝑙 is the model length and 𝑇 is the model thickness. The values of 𝑙 and 𝑇 are known 
for different infarct models (Table 5.1). The values of 𝑓𝑥 and 𝑓𝑦 were captured from the predicted 
reaction forces at C7 and C8 (for 𝑓𝑥) and C5 and C6 (for 𝑓𝑦) (Figure 5.2) respectively. 
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The nodal strain was derived from the biaxial displacement of the four reference points 
(Figure 5.2). Cartesian coordinates of these points were captured at each increment of the quasi-
static simulation. The equations governed the strain calculation was adopted from previous studies 
(Hoffman and Grigg 1984; Humphrey et al. 1987; Sacks 2000).  



































where 𝐸𝑥𝑥 and 𝐸𝑦𝑦 are the nodal strain, ∆𝑥 and ∆𝑦 are the change in nodal coordinates, and ∆𝑢 
and ∆𝑣 are the change in nodal displacement in the circumferential and longitudinal directions, 
respectively.  
5.2.6 Validation of stress-strain computation  
The real-time biaxial loading force and displacement (𝑥-𝑦 positions) of the optical markers were 
recorded as raw data by the biaxial device during experiment. These raw data were utilized to 
validate the stress and strain computing formulas described in section 5.2.5. 
Raw data of 3 random samples were obtained. Biaxial stress and strain were computed for each 
sample using Eqs. 5-8 to 5-11. The validity of these equations was examined by comparing the 
computed stress-strain curves with the experimental curves. 
5.2.7 Mesh refinement verification 
The FE model underwent a mesh refinement study to evaluate the convergence of the numerical 
solution and to determine the optimum mesh density. Using global seeding, eight mesh densities 
were generated, as shown in Figure 5.4, utilizing linear hexahedral reduced-integration hybrid 
elements (C3D8RH). Table 5.3 shows the number of elements in each mesh.  
Fung orthotropic model and material parameters of healthy myocardium, adopted from Omens et 
al. (1993), were utilized as shown in Table 5.4. Five transmural layers of fibres were defined; -50° 
at epicardium to 80° at the endocardium. The model was subjected to 10% equibiaxial stretch. 
Computational results and simulation time were compared between mesh densities. 
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Table 5.3: Number of elements generated for mesh convergence study. 
Model Mesh 1 Mesh 2 Mesh 3 Mesh 4 Mesh 5 Mesh 6 Mesh 7 Mesh 8 
Number of 
elements 
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Table 5.4: Rat healthy myocardium material parameters, adopted from Omens et al.(1993), for 
Fung orthotropic model. 










𝑐 (kPa) 1.1 
 
5.2.8 Element type verification 
Aiming at determining the suitable element type, the sensitivity of the FE model to different types 
of elements was examined. Four models were developed with four different element types and a 
unique mesh density (Mesh 3 in Figure 5.4). Element types include: 
 Linear hexahedral reduced-integration hybrid elements (C3D8RH) 
 Linear hexahedral full-integration hybrid elements (C3D8H) 
 Quadratic hexahedral reduced-integration hybrid elements (C3D20RH) 
 Quadratic hexahedral full-integration hybrid elements (C3D20H) 
The material parameters shown in Table 5.4 were utilized. The models were subjected to 10% 
equibiaxial stretch and assigned 14 transmural layers of fibres. Stress-strain results and simulation 
time were compared between the models. 
5.2.9 Sensitivity to density of fibre layers 
The sensitivity of FE model to the density of the transmural fibre layers was studied in order to 
determine the optimum number of fibre layers to be incorporated in the model. It is important, 
however, to take into account the mesh density, particularly the number of transmural elements, 
since fibre angles are defined at element integration points (Abaqus 2012). The optimum FE mesh, 
as will be discussed later, was found to comprise 3 transmural elements. This mesh was utilized to 
develop 4 models in which 3, 5, 9 and 14 transmural fibre layers were defined respectively. A fifth 
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model with a fine mesh (14 transmural elements) and fibre layers (14 layers) was developed. A 
summary of models is presented in Table 5.5. All models were meshed using C3D8RH elements, 
assigned material parameters in Table 5.4 and subjected to 10% equibiaxial stretch. Biaxial stress-
strain results and simulation time of the 3-element models were compared to the model with the 
fine mesh.  
Table 5.5: Number of transmural elements vs. number of fibre layers in the models developed for 
evaluating the fibre-layers sensitivity study.  
Model name* No. of transmural elements No. of fibre layers 
3E-3F 3 3 
3E-5F 3 5 
3E-9F 3 9 
3E-14F 3 14 
14E-14F 14 14 
* “E” and “F” in a model name denote “Element” and “Fibre layer” respectively. 
5.3 Results 
5.3.1 Validation of stress-strain computation 
In Figure 5.5, the experimental biaxial stress-strain data is plotted together with the stress-strain 
data computed using Eqs. 5-8 to 5-11. The computational data fitted the experimental data very 
well for samples 1 and 2, Figure 5.5 (a, b). For sample 3, Figure 5.5 (c), a good fit was observed in 
the circumferential direction, however, the computationally predicted strain slightly 
underestimated the experimental strain in the longitudinal direction above ~15% of strain.  




Figure 5.5: Experimental and computational biaxial stress-strain relationship in three samples: 
(a) Sample 1, (b) Sample 2 and (c) Sample 3. Computational stress and strain was calculated from 
raw experimental data of force and x-y positions of the optical markers. 
5.3.2 Mesh refinement  
The convergence of biaxial stress and strain with mesh refinement is illustrated in Figure 5.6. The 
peak numerical solutions from each mesh was normalized by the equivalent value from the coarse 
mesh (i.e. Mesh 1). The same circumferential strain (𝐸𝑥𝑥) was predicted by all mesh densities. 
Other numerical results converged at Mesh 3. Biaxial stresses, 𝑆𝑥𝑥 and 𝑆𝑦𝑦, exhibited a slight 
fluctuation beyond Mesh 3, however, results from the finest mesh (Mesh 8) were comparable to 
Mesh 3. Comparing the simulation time, Mesh 3 consumed 97% less time than the Mesh 8 as 
illustrated in Table 5.6. As such, Mesh 3 was considered the optimum mesh density for the biaxial 
FE model. 
 
Figure 5.6: Convergence of numerical results with increasing mesh density. 
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Table 5.6: Simulation time consumed by different meshes. 
Model Mesh 1 Mesh 2 Mesh 3 Mesh 4 Mesh 5 Mesh 6 Mesh 7 Mesh 8 
CPU time [sec] 4 16.4 26.6 68.1 94.2 219.7 417.6 785.1 
 
5.3.3 Element type verification 
Figure 5.7 shows the biaxial stress-strain relationship predicted by the FE model using different 
element types.  A slight deviation between models was observed at higher strain, however, up to 
5% strain all types of element predicted the same stress-strain data. This indicated that the 
numerical solutions were predictable by different element types within the strain range designated 
in this study. Comparing the computational cost between different element types, as illustrated in 
Table 5.7, C3D8RH showed the least simulation time. As such, C3D8RH was considered the 
optimal element type and utilized in the FE model. 
 
 
Figure 5.7: Stress-strain relationship in circumferential (a) and longitudinal (b) directions obtained 
from different types of elements. 
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Table 5.7: Simulation time of element verification models. 
Model C3D8RH C3D8H C3D20RH C3D20H 
CPU time [sec] 47.5 63.5   207.3 414.3 
 
5.3.4 Sensitivity to density of fibre layers 
The finest model in terms of the number of fibre layers and elements was 14E-14F. The numerical 
results predicted by this model were assumed to be the most accurate. Figure 5.8 shows a 
comparison between the biaxial stress-strain relationships predicted by the 3-element models 
(i.e. 3E-3F, -5F, -9F and -14F) and the one predicted by 14E-14F. The biaxial data predicted by 
3E-3F and 3E-5F was identical and thus represented by a single curve for illustrative purposes. At 
low strains, the variation between the curves was minimal. As the strain exceeded ~8% the 
variation between different models became more distinct. The model that best fitted the 14E-14F 
stress-strain data was 3E-14F. Considering computational cost, changing the number of fibre 
layers had a small effect on the simulation time when the mesh density remained fixed as illustrated 
in Table 5.8. The 14E-14F model required 300-fold the time of 3E-14F. Hence, using 14 
transmural layers of fibres was considered to be optimal when combined with Mesh 3. 




Figure 5.8: Stress-strain relationship in circumferential (a) and longitudinal (b) directions of 
selected models with different fibre layers and mesh densities. 
 
Table 5.8: Simulation time of models used to study the sensitivity to fibre layers. 
Model 3E-3F 3E-5F 3E-9F 3E-14F  14E-14F 
CPU time [sec] 68.5 68.1 40 47.5  14221 
 
5.3.5 Identified material parameters of infarcts 
The identified Fung orthotropic material parameters for different infarct groups are shown in 
Table 5.9. The MAPE value represents the error between the experimental and computational data 
for the relative infarct group. The FE model predictions best approximated the experimental data 
of the 28d group with 3.0% error. The worst approximation was for the 7d group with 3.6% error. 
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Table 5.9: Identified Fung orthotropic material parameters for immediate, 7, 14 and 28 day infarcts. 
The MAPE value represents the mean absolute percentage error between the experimentally 
measured data and the fitted FE model predictions.  
Material parameter 0d 7d 14d 28d 
𝑏1111 64.31 176.09 16.38 159.65 
𝑏1122 14.08 -70.92 -16.16 -25.52 
𝑏2222 48.60 83.95 128.78 38.15 
𝑏1133 20.51 81.15 -11.62 1.10 
𝑏2233 -39.35 -84.99 -6.94 -31.44 
𝑏3333 152.06 175.57 172.58 116.40 
𝑏1212 68.31 176.54 77.86 18.56 
𝑏1313 111.94 175.11 130.73 127.89 
𝑏2323 63.54 158.40 189.56 65.77 
𝑐 (kPa) 0.201 0.133 0.146 0.695 
MAPE 0.032 0.036 0.032 0.030 
 
Comparisons between the experimental data and the best fitted FE model results are shown in 
Figure 5.9, Figure 5.10, Figure 5.11 and Figure 5.12 for the immediate, 7d, 14d and 28d infarct 
groups, respectively. Most of the numerical predictions fell within the standard deviation tolerance 
of the experimental data for different infarcts. Mechanical coupling exhibited by the experimental 
data, indicated by the negative circumferential strains, at 30:60 loading protocol was well predicted 
by the FE model for all infarcts as illustrated in Figures 5.9-12 (c). With exception to the 28d 
group, FE models were not able to closely approximate the circumferential stress-strain data of 
the 60:30 protocol, Figures 5.9-12 (e). 




Figure 5.9: Best fit of FE model predictions to the experimental data for the immediate (0d) infarct 
group in each direction from three loading protocol. Stress axes are shown at variable range. Error 
bars represent the standard deviation. (a) Circumferential direction from 60:60 N/m protocol. (b) 
Longitudinal direction from 60:60 N/m protocol. (c) Circumferential direction from 30:60 N/m 
protocol. (d) Longitudinal direction from 30:60 N/m protocol. (e) Circumferential direction from 
60:30 N/m protocol. (f) Longitudinal direction from 60:30 N/m protocol.  
 




Figure 5.10: Best fit of FE model predictions to the experimental data for the 7d infarct group in 
each direction from three loading protocol. Stress axes are shown at variable range. Error bars 
represent the standard deviation. (a) Circumferential direction from 60:60 N/m protocol. (b) 
Longitudinal direction from 60:60 N/m protocol. (c) Circumferential direction from 30:60 N/m 
protocol. (d) Longitudinal direction from 30:60 N/m protocol. (e) Circumferential direction from 
60:30 N/m protocol. (f) Longitudinal direction from 60:30 N/m protocol. 
 




Figure 5.11: Best fit of FE model predictions to the experimental data for the 14d infarct group in 
each direction from three loading protocol. Stress axes are shown at variable range. Error bars 
represent the standard deviation. (a) Circumferential direction from 60:60 N/m protocol. (b) 
Longitudinal direction from 60:60 N/m protocol. (c) Circumferential direction from 30:60 N/m 
protocol. (d) Longitudinal direction from 30:60 N/m protocol. (e) Circumferential direction from 
60:30 N/m protocol. (f) Longitudinal direction from 60:30 N/m protocol.  
 
 




Figure 5.12: Best fit of FE model predictions to the experimental data for the 28d infarct group in 
each direction from three loading protocol. Stress axes are shown at variable range. Error bars 
represent the standard deviation. (a) Circumferential direction from 60:60 N/m protocol. (b) 
Longitudinal direction from 60:60 N/m protocol. (c) Circumferential direction from 30:60 N/m 
protocol. (d) Longitudinal direction from 30:60 N/m protocol. (e) Circumferential direction from 
60:30 N/m protocol. (f) Longitudinal direction from 60:30 N/m protocol. 
5.4 Discussion 
In this study, an inverse approach was applied to identify material parameters of the orthotropic 
case of Fung constitutive law for healing infarcts. Utilizing the mechanical data presented in 
Chapter 4, FE models were developed and numerical solutions were fitted to the experimental 
data through GA-based optimization of the material parameters. The material parameters 
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5.4.1 Model development 
The 3D model was developed using the full geometry of the tissue sample. Partial geometries in 
conjunction with symmetric boundary conditions were not applicable in this study because of the 
anisotropy of the infarct. Stretching the model using 2 cylinders in each direction while 
constraining the movement of the 2 opposite cylinders produced uniform stress field in the central 
target area as illustrated in Figure 5.13. The locations of the reference points (black dots) were far 
enough from the areas of high stress concentration near the needles. This confirms that the model 
did not predict false strains due to the improper deformation of the sample (Sun et al. 2005).  
 
Figure 5.13: Von Mises stress (MPa) distribution in a fully deformed biaxial FE model illustrating 
the uniform stress field in the central target area. Locations of reference points are indicated by 
black dots. 
5.4.2 Model validation and verification tests 
The FE model was validated by examining its capability to computationally reproduce the 
experimental stress-strain data of three samples utilizing the real-time force and markers 
displacement recorded by the biaxial testing system. Stress and strain were computed using 
Eqs. 5-8 to 5-11. The computational data perfectly fitted the experimental data in two samples, 
Figure 5.5 (a, b). However, the computed longitudinal strain in the third sample underestimated 
the experimental strain above ~15%. This error was considered minor since the FE model solution 
was aimed to fit the experimental data for up to 5% of biaxial strain, as described in section 5.2.4. 
Therefore, it was confirmed that the experimental data obtained from the biaxial testing system 
and the computational data predicted by the FE model were developed using the same approach. 
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This was important to prevent possible errors from the mismatch between the two methods which 
would affect the accuracy of the optimized material parameters. 
A single iteration in the optimization process of the material parameters included three simulations; 
M6060, M3060 and M60:30 (Figure 5.3). The optimization process could reach 1000 loops. As 
such, the computational cost is an important factor in this study since up to 3000 simulations may 
run to optimize the material parameters of a single infarct group. The mesh density, element type 
and fibre orientation are model attributes which influence the predicted numerical solution as well 
as the computational cost of the model. Therefore, the FE model underwent verification tests to 
choose the optimum mesh density, element type and density of fibre layers taking into account the 
computational cost.  
Using 1896 elements in Mesh 3 (Figure 5.6) was found to produce, in a significantly less cost, 
numerical results that are comparable to the finest mesh (Mesh 8) which contained 29817 elements. 
The model exhibited insensitivity to elements type suggesting that the simulation time was the only 
considered aspect for choosing the optimal element type.   
One limitation of the developed model was the utilization of a generic muscle fibre orientation, 
obtained from literature  (Chen et al. 2003), to model the material orientation in the infarcts. 
Although this approach can be valid for the immediate (0d) infarct due to the presence of the 
muscle fibres (Holmes et al. 2005), it may not be appropriate for the other healing stages of infarcts 
(i.e. 7d, 14d and 28d) since the orientation of collagen fibres is possibly different. Also using unique 
fibre orientation for all the simulations ignored the change in fibre orientations observed for the 
different stages of infarct healing. Ideally, the orientations of collagen fibres in different infarct 
groups should have been measured and incorporated in the model. Since this was not feasible, a 
generic muscle fibre orientation was employed.  
The fibre orientation was defined through 14 transmural layers linearly varied from -50° at the 
epicardial layer and 80° at the endocardial layer. In a single fibre layer, the fibres were assumed to 
have a unique angle, i.e. no in-plane change in angle. Reduced integrated elements contain one 
centroid integration point. The optimum mesh of the model comprised 3 transmural elements 
indicating that 3 fibre angles will be assigned.  The study of refining the fibre layers suggested that 
the FE model was insensitive to change in fibre density at low biaxial strains. Additionally, 
combining the computationally inexpensive optimum mesh with 14 fibre layers delivered the same 
data as obtained with a very fine 14-element mesh. Consequently, the FE model utilized for the 
optimization of material parameters comprised 14 transmural fibre layers.  
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5.4.3 Identification of Fung material parameters 
It has been discussed that myocardium may have orthotropic structure and that orthotropic 
constitutive models better describe the mechanical behaviour of myocardium than transversely 
anisotropic models (Usyk et al. 2000; Costa et al. 2001; LeGrice et al. 2001). In the present study, 
an orthotropic constitutive law was used to model the mechanical properties of the different infarct 
stages.  
One difficulty in optimizing the material parameters in this model was the positive definiteness 
condition of the parameter matrix (Eq. 5-3) in the unloaded state. The fulfilment of the 
constraints described in Eqs.  
5-4 and 5-5 adds more complexity to the definition of the optimization process. In the present 
study, such constraints were not included in the GA. Instead, it was verified that the generated sets 
of parameters satisfied the positive definiteness condition. A similar approach was applied by 
Wang et al. (2006). In a generation, random sets of material parameters are defined by the GA. It 
is required to test these sets for violation of the constraints before they are passed to the model. 
A pilot study suggested that eliminating an entire violating set was not always a good approach 
since such violation can sometimes be treated, for example, by adjusting the value of a single 
parameter in the set. Following several trials, an approach of classifying these sets according to the 
violation severity was introduced. The set that violates Constraints 1 and 2 is the worst and 
therefore penalized using a relatively large OBJ value (OBJ=50). If only Const-1 is violated, the 
set is penalized with less OBJ value (OBJ=1). Similarly, if only Constraint 2 is violated, the set is 
penalized with OBJ=0.5. Penalizing the undesired sets will rank them at the bottom of the list so 
that they are not included in the formation of the next generation. This way the GA is biased in 
the definition of the new generation. As a result, the violation disappeared in most of the newly 
formed sets of parameters at the 4th or 5th generation. In spite of its simplicity, this approach 
worked very well for the current study. 
A shortcoming of the current study was the employment of biaxial data to fit material parameters 
of orthotropic material law. The negative values in some of the identified parameters, e.g. 𝑏1122 
and 𝑏2233, did not make good physical sense and indicated “overfitting”. In other words, the 
biaxial tests were not able to provide sufficient data to fit all the parameters of the orthotropic 
constitutive law. Holzapfel and Ogden (2009) discussed the limitation of using biaxial data alone 
to fit orthotropic constitutive law. They emphasized the need for more comprehensive mechanical 
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characterization which include shear data at different orientation in order to appropriately capture 




6 Micromechanics of biomaterial injectate 
and infarcted myocardium during 
diastole: Finite element investigation 
6.1 Introduction 
Injection of biomaterial into the infarcted ventricular wall is an evolving therapy for myocardial 
infarction (MI). Biological (Dai et al. 2005) and synthetic (Kadner et al. 2012)  materials  have 
shown beneficial outcomes; preventing the expansion of the infarct and limiting the adverse 
ventricular remodelling. Such beneficial outcome is attributed to the mechanical support of the 
damaged tissue by the injected material (Wall et al. 2006). In addition to the mechanical support, 
biomaterial injectates can be utilized as carriers for the delivery of stem cells and growth factors 
aiming at restoring the contractility in the injured myocardium (Lu et al. 2009; Ruvinov et al. 2011; 
Singelyn and Christman 2011) and cardioprotection of the infarcted heart through paracrine 
signalling (Uemura et al. 2006; Mirotsou et al. 2007).  
Preclinical research has been devoted to understand the underlying mechanics of the acellular 
biomaterial injectate MI therapy. Morita et al. (2011) injected tissue filler material into infarcted 
sheep hearts. Observing an improved infarct expansion and remodelling at 8 weeks after infarction, 
they claimed that infarct thickening and stiffening was beneficial and achievable through 
biomaterial injection. Ifkovits et al. (2010) investigated the impact of injecting two hyaluronic acid 
hydrogels with 8 and 43 kPa moduli on the remodelling response of ovine MI model. They found 
that the higher modulus hydrogel was superior in terms of functional outcomes and infarct 
expansion. Kichula et al. (2014) utilized biaxial testing to demonstrate the anisotropic stiffening of 
the tissue/hydrogel composite region when hydrogel was injected into ovine hearts in vitro. A 
finite element (FE) model of acute MI showed a decreasing wall myofibre stresses with increasing 
composite stiffness. This study revealed the importance of optimizing the injectate properties. 




FE approaches have been applied in the investigation of biomaterial injection therapy for MI. 
Wenk et al. (2009) utilized FE models with analytical approach to estimate the optimum patterns 
of injections based on minimizing myofibre stresses and maximizing stroke volume. 
Kortsmit et al. (2013; 2013b) developed FE models of canine hearts to study the effect of the 
hydrogel injectate on the healing infarct taking into account different hydrogel geometries.  
The mechanical investigations of MI biomaterial-injectate therapy presented in literature focused 
on the “macroscopic” level of the problem. In the current study, an insight is provided into 
the micromechanics of a hydrogel injectate in the infarct zone during the diastolic filling of a rat 
left ventricle (LV). A FE end-systolic LV model was developed from cardiac magnetic resonance 
(CMR) image data. Increasing intraventricular pressure was applied to simulate the passive filling. 
The deformation of a small hexahedral volume in the anterior midwall region, referred to as block, 
of the healthy LV was measured. Assuming a block of the same dimensions comprising infarcted 
tissue and interleaved gel injectate (referred to as composite), the micromechanics of biomaterial 
injectate and infarcted tissue was investigated. Infarct-gel composites of the same geometrical 
distribution but different material properties of both tissue and gel were studied utilizing 7 and 
28 day infarcts in conjunction with 3 gels of different stiffness. The geometrical model of the 
infarct-gel composite block was developed from histological micrographs using the approach 
described in Chapter 3 while utilizing the infarct material parameters identified in Chapter 5. 
6.2 Materials and methods 
6.2.1 Left ventricular model 
A FE model was developed to simulate diastolic filling of a healthy rat LV. This model provided 
the mechanical domain wherein the micromechanics of biomaterial injectate was aimed to be 
studied. The diastolic passive filling was modelled by applying an increasing pressure to the 
endocardium of an end-systolic (ES) LV geometry until a predefined end-diastolic (ED) cavity 
volume was reached. 
An ES geometry of a LV was reconstructed using the approach and CMR image data previously 
presented in Chapter 3. In brief, CMR image data of a healthy rat heart was obtained using a 
custom built small animal coil in a 3.0T Magnetic Resonance Imaging (MRI) system. An ES short-
axis CMR image stack was imported in Simpleware (Simpleware Ltd., Exeter, UK). A special mask 
was applied to segment the LV in each slice. By stacking the masks, a 3D geometry of the LV was 




developed. The model was meshed using linear tetrahedral reduced-integration hybrid elements 
(C3D4H) as shown in Figure 6.1 (a).  
The model was imported in Abaqus CAE 6.12-2 (Dassault Systèmes, Providence, RI, USA) for 
FE analysis. Fung orthotropic model and material parameters of healthy myocardium, adopted 
from Omens et al. (1993), were utilized as shown in Table 6.1. 
Table 6.1: Rat healthy myocardium material parameters, adopted from Omens et al.(1993), for 
Fung orthotropic material model. 










𝑐 (kPa) 1.1 
 
The orientation of myofibres was incorporated in the LV model using a user-defined material 
orientation subroutine (ORIENT) in Abaqus. The subroutine was utilized to define fibre 
orientation through 5 transmural layers of fibre angles. The fibre angles ranged linearly from -50° 
at the epicardial layer to 80° at the endocardial layer (Chen et al. 2003). At the apex, the fibres were 
oriented circumferentially i.e. assigned 0° angle. At the interface between the apex and proximal 
region of the LV, the epicardial and endocardial layers were assigned -25° and 40° respectively. 
These midpoint angles were introduced to achieve the spiral orientation of fibres observed in a rat 
heart (Hautemann 2007). 
 





Figure 6.1: Left ventricle end-systolic model. (a) The finite element mesh. (b) Fibre orientation at 
the epicardial layer. (c) Fibre orientation at the endocardial layer. 
To apply boundary conditions, a cylindrical coordinate system (𝑟-𝜃-𝑧) was introduced in the model 
where 𝑟, 𝜃 and 𝑧 represented the radial, circumferential and longitudinal axes respectively. 
Displacement boundary conditions were applied to the entire base surface of the LV. The 
displacement of the surface nodes was constrained in the circumferential and longitudinal 
directions allowing a movement in the radial direction only. 
The ES LV model was loaded by applying a pressure to the endocardial surface. The pressure was 
linearly increased until the LV cavity volume matched a target value. This target value represented 
the ED cavity volume which was measured from the CMR data using a specialized cardiovascular 
image analysis software; Segment v1.8 R1021 (Heiberg et al. 2010). The target ED volume was 
170 μl and was obtained by the model at ED pressure of 21 mmHg (2.8 kPa). 
6.2.2 Prediction of microscopic deformation in the anterior wall  
During diastolic filling of the LV, the deformation of a small anterior midwall tissue volume was 
recorded and represented in forms of normal and shear strains. This small volume henceforth will 
be referred to as “block”.  
A block with dimensions ~300×300×300 μm was developed, meshed using linear hexahedral 
reduced-integration hybrid elements (C3D8RH) and assigned the healthy myocardium material 
model in Table 6.1. The block was embedded in the LV midwall as illustrated in Figure 6.2. 
Embedded region constraint (Abaqus 2012) was applied to the block so that the response of the 




LV elements constrained the translational degrees of freedom of the block nodes. The elements 
were assigned the local fibre orientation based on the position of the block within the LV wall. 
 
Figure 6.2: Anterior (a) and superior (b) views of the left ventricle model showing the location of 
the analytical block used to study the microscopic deformation in the anterior wall during diastolic 
filling. The model is partially translucent for illustration purposes. 
The deformation of the block was determined by capturing and analysing the local displacements 
of its surfaces. This was implemented by defining a reference point in the centre of each face of 
the block and by defining a local Cartesian coordinate system at one corner as shown in 
Figure 6.3 (a). The reference points were tied to their surfaces using tie constraints (Abaqus 2012). 
The local coordinate system was defined as a movable system following the corner so as to omit 
the rigid body displacement of the block. The coordinate system was oriented so that the positive 
𝑥, 𝑦 and 𝑧 directions were in the circumferential, radial and longitudinal directions of the LV.  
The 𝑥, 𝑦 and 𝑧 components of a reference point displacement, and thus the surface, were captured 
during diastolic filling and analysed to quantify the block deformation. The deformation was 
represented in form of normal (𝐸𝑥𝑥 , 𝐸𝑦𝑦 , 𝐸𝑧𝑧) and shear (𝐸𝑥𝑦 , 𝐸𝑦𝑥 , 𝐸𝑧𝑥 , 𝐸𝑥𝑧 , 𝐸𝑦𝑧 , 𝐸𝑧𝑦) strains 
calculated by normalizing the displacement (∆𝑥 , ∆𝑦 , ∆𝑧) by the respective block dimension (𝑥 , 
𝑦 , 𝑧) as illustrated in Figure 6.3 (b). 





Figure 6.3: (a) Diagram of the block showing the predefined reference points and the local 
coordinate system. (b) The different forms of strains calculated from surface displacement of the 











6.2.3 Infarct-gel composite block model 
A block model containing a composite of infarcted tissue and hydrogel was developed to study 
the micromechanics of biomaterial injectate during diastolic filling of the LV. Different infarct-gel 
composites were studied utilizing 7 and 28 day infarcts in conjunction with 3 gels of different 
stiffness. 
The geometry of the infarct-gel composite block was developed from the histological micrographs 
of polyethylene glycol (PEG) gel using the approach previously described in Chapter 3. In brief, 
MI was induced in a rat heart followed by injection of PEG gel. The heart was harvested, sectioned 
at ~300 μm on a cryostat and mounted using DAPI mount. Images of the sections were acquired 
using an Eclipse 90i Fluorescent Microscope with digital camera. Assuming a uniform shape of 
tissue and gel within a longitudinal extension of 300 μm, copies of a single image were imported 
in Simpleware to reconstruct a 300 μm thick block. As demonstrated in Figure 6.4 (a, b), tissue 
and gel were segmented within a square field using red and blue spatial masks, respectively. The 3D 
geometry of the tissue-gel composite was reconstructed and meshed as shown in Figure 6.4 (c).  
The mesh was composed of a mixture of 5336 linear hexahedral (C3D8RH) and 65467 linear 
tetrahedral (C3D4H) reduced-integration hybrid elements. The block volume was 0.031 mm3 
(0.0159 mm3 tissue; 0.0151 mm3 gel). The tissue and gel sections were identified as separate element 
sets in the continuum of the block, i.e. allowing no slip between the two materials. 
 
Figure 6.4: Development of tissue-gel composite block model. (a) Greyscale histology image from 
which tissue and gel were segmented. Gel appears white. Square indicates the segmented field. 
(b) Segmentation of tissue and gel. Tissue appears red and gel appears blue. (c) 3D developed mesh 
of the block. 
The composite block mesh was imported in Abaqus. Different material models were assigned to 
element sets representing tissue and gel. Fung orthotropic material model was employed for the 




tissue section utilizing material parameters identified in Chapter 5. The gel was modelled as 
Neo-Hookean isotropic hyperelastic material described in terms of strain energy function (𝑊): 
 𝑊 = 𝑐10(𝐼1̅ − 3)  6-1 
where 𝑐10 is the material parameter and 𝐼1̅ is the first invariant of the left Cauchy-Green 
deformation tensor.  
Different combinations of infarct and gel materials were utilized based on the 7d and 28d infarct 
properties and gels of different stiffness. Material parameters of 7d and 28d infarcts are shown in 
Table 6.2. For PEG hydrogel material, 𝑐10 was 12.3 kPa (Phelp 2012). Additional softer (𝑐10 = 
3 kPa) and stiffer (𝑐10 = 20 kPa) gel materials were employed, denoted by G03 and G20 
respectively. These material properties were chosen in order to account for very early and late 
phases of infarct healing and the variation in the stiffness of injectable biomaterials (Wall et al. 
2006).  
Table 6.2: Fung orthotropic material parameters for 7d and 28 day infarcts (adopted from 
Chapter 5). 
Material parameter 7d 28d 
𝑏1111 176.09 159.65 
𝑏1122 -70.92 -25.52 
𝑏2222 83.95 38.15 
𝑏1133 81.15 1.10 
𝑏2233 -84.99 -31.44 
𝑏3333 175.57 116.40 
𝑏1212 176.54 18.56 
𝑏1313 175.11 127.89 
𝑏2323 158.40 65.77 
𝑐 (kPa) 0.133 0.695 
 
For the purpose of comparison, block models of untreated (without biomaterial injectate) infarcted 
tissue were developed by assigning a single infarct material model to both sections of the block. 
However, predicted results were considered only from the element set representing the tissue 
section so that the comparison between tissue mechanics in different models was based on the 
same set of elements. Table 6.3 summarizes the different models.  
 









Tissue Section Material Gel Section Material 
7 day infarct (untreated) I 7d  7d 
7 day infarct with soft gel I-G03 7d  G03   (𝑐10= 3kPa) 
7 day infarct with PEG gel I-PEG 7d PEG  (𝑐10= 12.3kPa) 
7 day infarct with stiff gel I-G20 7d G20   (𝑐10= 20kPa) 
28 day infarct (untreated) I 28d 28d 
28 day infarct with soft gel I-G03 28d  G03   (𝑐10= 3kPa) 
28 day infarct with PEG gel I-PEG 28d PEG  (𝑐10= 12.3kPa) 
28 day infarct with stiff gel I-G20 28d G20   (𝑐10= 20kPa) 
I = Infarct, G = Gel, d = day. 
 
The deformation of the composite block associated with diastolic filling was simulated using the 
submodel approach (Abaqus 2012). The submodel is a modelling technique used to study in detail 
an area of interest in a model. It is based on simulating the deformation of a “global” coarse-mesh 
model. The output of this global model is then utilized to drive a fine-mesh “submodel” which 
forms a small region of the global model.  
In the present study, the LV model represented the global model whereas the composite block 
formed the submodel (region of interest). The composite block was virtually positioned in the 
anterior midwall of the LV, in the fashion illustrated in Figure 6.2, and was assigned the local fibre 
orientation. The displacement output field from the LV model was utilized to define the 
displacement of the boundary nodes on the block model shown in Figure 6.5.  





Figure 6.5: The boundary nodes of the composite block model. 
Infarcted myocardium is stiffer than healthy myocardium. As such, infarcts deform to a lesser 
extent during cardiac cycle compared to healthy tissue. In our study, the displacement output field 
used to define the deformation of the untreated infarct and composite blocks was obtained from 
diastolic filling of a healthy LV. To account for the attenuation of deformation in infarcts and 
composites, these blocks were deformed up to 15% only of diastole phase. This fraction was 
estimated from in vivo strain measurements on healthy and infarcted hearts found in literature.  
The circumferential strain of rat infarcts could be reduced by up to 80-90% compared to healthy 
myocardium (Fomovsky and Holmes 2010). MRI tagging measurements on human subjects 
showed 86% average decrease in the circumferential strain of an infarct compared to healthy 
control myocardium (Bogaert et al. 2000). In reality, increasing the stiffness of the gel is expected 
to further decrease the deformation of treated region during cardiac cycle. However, this was not 
implemented in the current models to ensure consistency necessary in models inter-comparison. 
Mean and maximum strain and stress predicted by tissue and gel sections in different models were 
compared. The calculation of mean and maximum results excluded elements with unrealistically 
extreme stress values caused by the boundary conditions, e.g. at marginal elements.  
6.3 Results 
6.3.1 Microstructural deformation in the anterior wall 
The surface displacements of the tissue block in 𝑥, 𝑦 and 𝑧 directions during LV diastolic filling 
are shown in Figure 6.6. The displacements in 𝑦 (radial) direction, Figure 6.6 (b), were the largest 




compared to the other directions with a maximum ED displacement of 68 μm predicted for 
surface C`. The block surfaces exhibited relatively small displacements in 𝑧 (longitudinal) direction, 
Figure 6.6 (c), with a maximum of 14 μm predicted for surface C`. In 𝑥 (circumferential) direction, 
Figure 6.6 (a), a maximum displacement of 40.5 μm was predicted for surface A`. 
The strain components calculated from the relative displacement of block surfaces at the ED time 
point are shown in Table 6.4. Tensile deformation was predicted in the circumferential (i.e. 𝐸𝑥𝑥) 
and longitudinal (i.e. 𝐸𝑧𝑧) directions whereas compressive deformation was observed in the radial 
direction (i.e. 𝐸𝑦𝑦). The maximum normal strain was 𝐸𝑦𝑦 = -10.93 % based on the relative 
displacement of surface B and B` in the radial direction. Similarly, the maximum shear strain was 
𝐸𝑦𝑧 = 20.46 % based on the relative displacement of surface C and C` in the radial direction. The 
minimum shear strain was 𝐸𝑦𝑧 = 0.96 and also predicted for C and C`, however, from their relative 
displacement in the circumferential direction. 
Table 6.4: End-diastolic strain components predicted by analytical block in the anterior midwall of 
left ventricle.   
ED Strain (%) 
𝐸𝑥𝑥  𝐸𝑦𝑦  𝐸𝑧𝑧 
8.53  -10.93  4.61 
𝐸𝑥𝑦  𝐸𝑦𝑥  𝐸𝑧𝑥 
3.86  9.81  -3.54 
𝐸𝑥𝑧  𝐸𝑦𝑧  𝐸𝑧𝑦 
0.96  20.46  3.29 
 





Figure 6.6: Displacement of surfaces of the block model during LV diastolic filling in 𝑥 (a) 𝑦 (b) 
and 𝑧 (c) directions. The panel in the corner was readopted from Figure 6.3 for illustration. The 
arrow denotes the end-diastolic pressure. 
6.3.2 End-diastolic strain and stress  
In Figure 6.7, the mean ED strain and stress predicted in tissue sections are shown for the different 
models described in Table 6.3. The average strain in fibre direction, Figure 6.7 (a), was 0.009 for 
7d and 28d untreated infarcts and decreased to 0.006 and 0.007 in the G03-treated infarcts, 
respectively. Increasing the gel stiffness in composites resulted in an increase in the infarct strain 
at both infarct stages.  A similar trend was observed in the cross-fibre direction strain, Figure 6.7 
(b), with the exception that different tissue sections exhibited negative strains. 
ED 





Figure 6.7: Mean end-diastolic fibre and cross-fibre strain and stress predicted in tissue sections of 
different blocks. (a)  Fibre strain. (b) Cross-fibre strain. (c) Fibre stress. (d) Cross-fibre stress.  
The stress in the fibre direction, Figure 6.7 (c), was decreased in 7d and 28d infarcts by 65 % and 
73 %, respectively, as a result of the soft injectate; G03. An increase in fibre stress was observed 
in both infarct stages with the increase in gel stiffness. The 7d infarct treated with the stiff injectate, 
G20, exhibited a fibre stress of 23.6 kPa exceeding the stress exhibited by the untreated infarct 
(22.1 kPa). As shown in Figure 6.7 (d), the cross-fibre stresses were slightly lower than the fibre 
stresses with a very comparable trend.  
Figure 6.8 illustrates the maximum ED strain and stress in tissue sections of the different models. 
The maximum fibre strain, Figure 6.8 (a), was equal for all untreated and treated infarcts. Unlike 
the average data, the maximum cross-fibre strain, Figure 6.8 (b), showed positive values. 
The treated infarcts exhibited larger cross-fibre strains than the untreated infarcts and the strain 
level decreased as the injectate stiffness increased. The maximum fibre stress, Figure 6.8 (c), and 
cross-fibre stress, Figure 6.8 (d), showed a trend similar to the one observed for the average data.  





Figure 6.8: Maximum end-diastolic fibre and cross-fibre strain and stress predicted in tissue 
sections of different block models. (a) Fibre strain. (b) Cross-fibre strain. (c) Fibre stress. (d) Cross-




Figure 6.9: Mean and maximum end-diastolic maximum principal strain and stress predicted in gel 
sections of different composite blocks. (a) Mean strain. (b) Maximum strain. (c) Mean stress. (d) 
Maximum stress. 
Figure 6.9 shows the average and maximum ED maximum principal strain and stress predicted in 
the gel section of the different infarct-gel composites. As the gel stiffness increased, strain levels 




decreased, Figure 6.9 (a, b), and stress levels increased, Figure 6.9 (c, d), irrespective of the infarct 
stage. With the increase in infarct stiffness from 7d to 28d, the injectate average strain, 
Figure 6.9 (a), increased by 8 % (G03), 6 % (PEG) and 7% (G20). Similarly, G03, PEG and G20 
injectates experienced respectively a 16 %, 18 % and 18 % increase in gel average stress, 
Figure 6.9 (c), at 28d compared to 7d infarct stage. The largest maximum principal strain and stress, 
Figure 6.9 (b, d), exhibited similar trends to the average data. 
 
Figure 6.10: Distribution of fibre stress (kPa) in 7d infarct sections from different block models. 
Sections are shown partially for illustration purposes as indicated in the upper inset. (a) Untreated 
infarct. (b) G03-treated infarct. (c) PEG-treated infarct. (d) G20-treated infarct. Excluding stress 
concentrations from boundary conditions, the same stress scale is used for all plots. 
 




Contour plots of fibre stress in the 7d and 28d infarct sections are shown in Figure 6.10 and 
Figure 6.11, respectively. Contour plots of the maximum principal stress in the gel sections are 
shown in Figure 6.12. The stress distribution was not uniform in all of the tissue and gel sections 
wherein spots of stress concentrations were observed. 
 
Figure 6.11: Distribution of fibre stress (kPa) in 28d infarct sections from different block models. 
Sections are shown partially for illustration purposes as indicated in the upper inset. (a) Untreated 
infarct. (b) G03-treated infarct. (c) PEG-treated infarct. (d) G20-treated infarct. Excluding stress 
concentrations from boundary conditions, the same stress scale is used for all plots. 





Figure 6.12: Distribution of maximum principal stress (kPa) in gel sections from different 
composite block models. Sections are shown partially for illustration purposes as indicated in the 
upper inset. (a) Gel section of 7d-G03 composite. (b) Gel section of 7d-PEG composite. (c) Gel 
section of 7d-G20 composite. (d) Gel section of 28d-G03 composite. (e) Gel section of 28d-PEG 
composite. (f) Gel section of 28d-G20 composite. Excluding stress concentrations from boundary 
conditions, the same stress scale is used for all plots. 





The FE studies which previously investigated the mechanics of biomaterial injectates used either 
of two modelling approaches: 1) homogenised infarct-injectate region (Wall et al. 2006; Wenk et 
al. 2011b; Wise 2013) or 2) discrete representation of infarct and injectate with approximated 
geometries for the injectate (Wenk et al. 2009; Kortsmit et al. 2013; Miller et al. 2013; Kortsmit et 
al. 2013b; Kichula et al. 2014). In this study, a microstructural model of myocardium-injectate 
composite was utilized to computationally investigate the micromechanics of biomaterial injectates 
and surrounding infarcted myocardium during the diastolic phase of the cardiac cycle. The 
developed model realistically represented the microstructural distribution of the injectate observed 
in situ when delivering PEG hydrogels shown in Figure 3.1 (a) and Figure 3.2 (c). 
With this approach, a decrease in the fibre and cross-fibre stresses in the infarct section as a result 
of the injected biomaterial was demonstrated. This beneficial effect decreased as the stiffness of 
the biomaterial increased. On the other hand, the micromechanics of the injectate was influenced 
by the change in infarct stage.  
The effect of the injectate on reducing the infarct stress was demonstrated in previous studies 
(Wenk et al. 2009; Kortsmit et al. 2013; Miller et al. 2013; Kortsmit et al. 2013b; Kichula et al. 
2014). In this study, however, a micromechanical mechanism is proposed by which the injectate 
induces such reduction in the infarct stress during diastolic filling. It is suggested that the gel works 
as a force attenuating system reducing the force acting on tissue layers during the passive diastolic 
dilation of the LV and thus reducing the stress induced in these tissue layers. 
6.4.1 Microscopic deformation in the anterior wall 
The analysis of the surface displacements for the anterior midwall block during diastolic loading 
(Figure 6.6) revealed a complex deformation. The deformation involved normal and shear strains 
in the different orthogonal directions (Table 6.4).  
The approach of using a block geometry to analyse the local deformation in the ventricle wall has 
been employed in a study by Bogaert et al. (2000). They utilized cuboids to analyse the normal and 
shear strains LV deformation through CMR myocardial tagging of human hearts. However, the 
strains were calculated from the displacement of cuboid corners whereas in the current study the 
predicted strains were calculated from block surfaces. Bogaert et al. (2000) also reported the 
complex deformation and quantified such deformation using normal and shear strains. Another 
study that measured the in vivo strain on rat hearts was conducted by Fomovsky and Holmes 




(2010) who measured strains through epicardial sonomicrometer crystals. Table 6.5 compares the 
predicted normal strains to the in vivo experimental strain measurements from Fomovsky and 
Holmes (2010) and Bogaert et al. (2000). The in vivo strains adopted from these two studies were 
measured from ED to ES time points whereas the strains in our study were measured from ES to 
ED. To account for this difference, the model strains shown in Table 6.5 were recalculated from 
ED to ES and thus differ from the values previously shown in Table 6.4. 
Table 6.5: Comparison between FE predicted strains and in vivo strain measurements reported in 
other studies. 
Strain Description Model Prediction* (%) In vivo Measurements (%) 
Rat 1 Human 2 
𝐸𝑥𝑥  Circumferential -7.86 -7±4 -12.8±6.9 
𝐸𝑦𝑦  Radial 12.28 — 37.9±20.6 
𝐸𝑧𝑧  Longitudinal -4.41 -5±3 -13.3±7.9 
* Calculated from end-diastolic to end-systolic, 1 Fomovsky and Holmes (2010), 2 Bogaert et al. (2000) 
 
The predicted circumferential and longitudinal strain values; -7.86 % and -4.61 %, correlate with 
the rat in vivo strain; -7±4 % and -5±3 % respectively. However, there is a quantitative difference 
between model predications and human in vivo strains. This is expected since heart size and 
loading conditions are different. However, there are qualitative similarities. For example, both the 
model and the human strain values indicate that the maximum normal strain is in the radial 
direction and that there is mechanical coupling between the radial and other cardiac directions (i.e. 
circumferential and longitudinal). Despite these differences, the quantitative and qualitative 
similarities between the computational and experimental strains validated the LV model and 
showed that the micromechanical investigations were established using realistic loading conditions. 
6.4.2 Micromechanics of biomaterial injectate  
The investigation in the current study was based on two extreme infarct healing phases; the 7 and 
28 day infarcts. The infarct stiffness considerably increases between these two healing phases as 
previously discussed in Chapter 4. Therefore, these phases allowed us to evaluate the 
micromechanical impact of the gel on two distinct infarcts, and vice versa. Introducing three gels 
with different stiffness in the study was driven by the variety of injectate stiffness (Wall et al. 2006). 
Another motivation was the findings of a previous study (Ifkovits et al. 2010) which demonstrated 




that injecting a hyaluronic acid hydrogel with higher compressive modulus resulted in a reduced 
infarct expansion and LV dilation and improved function compared to lower modulus hydrogel. 
The tissue-gel composite model (Figure 6.4) was developed by extrusion of a 2D masks of tissue 
and gel from a single histology section. This resulted in 3D model of a uniform longitudinal shape. 
Since the slice-to-slice distance between histology sections were ~300 μm, there was no 
information on the change of tissue and/or gel structure between two subsequent sections. 
Therefore, it was assumed that within such small longitudinal distance the structure of tissue and 
gel was uniform. The segmented field in the histology image, Figure 6.4 (a), was specified so that 
the volume ratio between tissue and gel in the composite model was ~1:1. The reason was to 
reduce possible mechanical effects from predominance of specific material volume (Wise 2013). 
The composite model was developed as a single continuum structure where tissue and gel sections 
were identified through different sets of elements. Ideally, one would develop tissue and gel as 
separate structures and define contact between them. However, this was not feasible since 
information on the contact between tissue and injectate; such as friction coefficients, was not 
available. As such, assigning tissue and gel materials to different element sets was the only efficient 
way. This technique has been used in FE analysis of injectate-based MI therapy (Miller 2012; 
Kortsmit et al. 2013; Kortsmit et al. 2013b).  
The negative mean cross-fibre strains, Figure 6.7 (b), and positive mean cross-fibre stresses, 
Figure 6.7 (d), exhibited by different tissue sections can be attributed to the mechanical coupling 
between the tissue fibre and cross-fibre directions. Mechanical coupling between fibre and cross-
fibre directions has been reported for healthy myocardium (Ghaemi et al. 2009). In our 
study (Chapter 4), the mechanical coupling between circumferential and longitudinal directions of 
infarcted myocardium was observed and discussed. 
The deformation of all untreated and treated infarct block models was induced by the displacement 
of the boundary nodes (Figure 6.5). Although these nodes were displaced equally for all block 
models, the models exhibited different mean strains in both sections; i.e. the infarct, Figure 6.7 (a), 
and the gel, Figure 6.9 (a). This is attributed to the difference in the “internal” deformation of 
infarct and gel sections between the different models. Such internal deformation is illustrated by 
the distribution of the displacement field in the internal elements of the block sections as shown 
in Figure 6.13. Although the displacement distribution on the boundary elements was similar for 
the different models, the internal elements exhibited distinct distribution indicating differences in 
internal deformation.  





Figure 6.13: Distribution of resultant displacement (mm) in the infarct and gel sections of two 
block models; 7d infarct treated with G03 and 7d gel infarct treated with G20 gel. Sections are 
showing partially as illustrated in the panels. Internal elements exhibits different displacements in 
the same section of two different models (dotted circles). (a) 7d infarct section treated with G03. 
(b) 7d infarct section treated with G20. 
The G03-treated infarcts showed a decrease in mean fibre strain compared to the untreated 
infarcts, Figure 6.7 (a). The increase in the fibre strains of the treated infarcts was then associated 
with the increase in the gel stiffness. On the other hand, the mean gel strain decreased with 
increasing gel stiffness, Figure 6.9 (a). The infarct and gel are organized in layers. Considering that 




the deformation in the radial direction 𝐸𝑦𝑦 is the predominant normal deformation (Table 6.4), 
such layers can be represented by a system of transmural springs connected in series. These springs 
have separate stiffness factors; infarct stiffness (𝑘𝐼) and gel stiffness (𝑘𝐺). When 𝑘𝐼 = 𝑘𝐺 , 
extending or compressing this system will result in an equal deformation (strain) in both sections. 
However, when 𝑘𝐺 <  𝑘𝐼, applying the same extension/compression will result in an increased 
deformation in the gel and decreased deformation in the infarct. As  𝑘𝐺  increases, the gel strain 
will decrease and the infarct strain will increase until reaching the state of  𝑘𝐼 ≈ 𝑘𝐺 at which the 
gel strain will be minimum and infarct strain will be maximum. Hence, it can be argued that 
stiffness of the G20 gel and the 7d infarct is comparable.  
The results illustrated a beneficial reduction of stress levels in infarcts in the presence of gel, 
Figure 6.7 (c, d) and Figure 6.8 (c, d). Such beneficial impact has been observed in previous studies 
(Kortsmit et al. 2013; Miller et al. 2013; Kortsmit et al. 2013b; Kichula et al. 2014). However, 
the variation in gel stiffness induced distinct reactions. For the 7d infarct, only G03 and PEG gels 
showed beneficial effects. G20 gel slightly increased the fibre and cross-fibre stress in the tissue. 
For the 28d infarct, stress reduction was observed for all gel types. As discussed earlier, the 
predominant normal deformation during diastolic filling is in the radial direction and with a 
compressive nature. As such, a coupling tensile force is induced in the transverse direction which 
is proportionally related to the radial deformation. Assuming that the fibre stresses are associated 
with this induced tensile force, the less the radial deformation is (in the presence of gel) the less 
stress is induced in the fibres. In previous studies, the reduction in stresses after gel injection was 
attributed to the LV wall thickening (Wall et al. 2006) and/or the increased stiffness of the 
gel/infarct composite (Kichula et al. 2014). The current results suggest an additional mechanism 
by which the gel reduces the stress level. It is proposed that the gel attenuates the forces acting on 
the tissue by limiting the tissue deformation in the transverse direction during the passive diastolic 
dilation of the LV.  For the gel to reduce the force, however, the stiffness of the gel should be less 
than the infarct. This condition is implied by the elevated stress levels in the 7d infarct when treated 
with G20.  Ifkovits et al. (2010) showed that the high stiffness gels were superior to the low 
stiffness gels in terms of the long-term infarct expansion and LV function in a sheep infarct model. 
If we assume that this beneficial effect was associated with the attenuation in wall stresses (Wall et 
al. 2006), then it is likely that increasing the gel stiffness is beneficial during systole. However, the 
current study showed that softer gels are superior during diastole.  
The stiffness of the gels increase by 4-fold from G03 (𝑐10= 3 kPa) to PEG gel (𝑐10= 12.3 kPa) 
and by 1.6-fold from PEG to G20 gel (𝑐10= 20 kPa). These ratios were reflected in the predicted 




stresses. For example, mean fibre stress, Figure 6.7 (c), in 7d infarct increases by 2.3-fold from 
G03 to PEG and 1.3-fold from PEG to G20. Similarly for 28d infarct, stress increase by 2.3-fold 
(G03 to PEG) and 1.3-fold (PEG to G20). As the infarct heals, a particular gel experiences an 
increase in strain and stress, Figure 6.9 (a, c). These findings may be of interest in specific context. 
For example, the change in shear stress of the gel may indicate a change in the gel flow. Considering 
that gels may be utilized as cell carriers or scaffolds for tissue repair, the increase in gel strains alter 
the mechanical boundary condition which in turn may affect the growth of these cells (Billiar 
2011).  
6.4.3 Limitation 
A major limitation in this study is controlling the deformation of the untreated and treated infarct 
block models using the deformation of a healthy LV. Attempts were made to correct this conflict 
by reducing deformation in the composite blocks. A more accurate approach, however, might be 
necessary through modelling a treated infarct region (homogenised) in the LV for the different 






7 Conclusions and recommendations 
The aim of this research was the contribution to the understanding and advancement of the 
emerging therapies for acute myocardial infarction (MI) based on the injection of biomaterials into 
the ischemic myocardium, by way of studying the biomechanical mechanisms associated with this 
treatment. The objectives of the research included the following: 
1) To establish adequate computational models to simulate myocardial and ventricular 
mechanics.  
2) To investigate the in vivo intramyocardial three-dimensional (3D) microstructural 
spatial distribution of polymeric biomaterial injectate and utilize this geometric 
information in computational models. 
3) To establish constitutive models for infarcted myocardial tissue through biaxial 
mechanical testing. 
4) To computationally simulate the regional micromechanics of myocardium with 
interlaced polymeric biomaterial with particular reference to the infarct zone. 
5) To computationally investigate novel concepts for material-injection based MI 
therapy and preventive interventions for heart failure with regard to the 
biomechanical effects of biomaterial injection, and predict their influence on 
treatment outcomes. 
These objectives were met through a number of studies presented in this thesis. The following 
sections describe the main conclusions from the work presented in the previous chapters. 
Recommendations of possible extensions of the current research are proposed at the end. 
 
 





7.1.1 Geometrical model of heart and gel injectate 
Aiming at establishing computational models based on realistic geometry of gel injectate, we 
developed a biventricular cardiac rat model in combination with micro-detailed intramyocardial 
hydrogel injectate. The developed model provides realistic geometries for advanced computational 
investigations of biomaterial-injectate based MI therapies.  
While the reconstructed injectate geometry stemmed from acellular injections in the rat, the high 
level of geometrical detail not only allows studying of the injectate-myocardium micromechanics. 
It can also render the geometry suitable for the representation of the physical environment for 
cells in the cellular biomaterial injectate. Therefore, the developed model also promotes 
computational studies of cell mechanics and mechanobiology in MI therapies. 
7.1.2 Mechanical characterization of infarcted rat myocardium 
We comprehensively characterized the mechanical properties of healing infarcts in a rat model. 
This study revealed that healing infarcts in rat hearts are mechanically anisotropic with the 
circumferential direction being stiffer than the longitudinal direction. The degree of anisotropy 
may vary between healing stages according to the amount of directional load and the orientation 
of the deposited collagen. The latter plays a major role in inducing the in-plane mechanical 
coupling between the two major axes. 
As the infarct healing progresses, the circumferential and compressive stiffness increases more 
pronouncedly compared to the longitudinal stiffness. The presented data are essential for 
developing material models for healing infarcts and for setting a baseline for future mechanical 
assessment of biomaterial injectate impact on infarcted myocardium in rat models. 
7.1.3 Identification of material constants for healing infarcts 
The biaxial mechanical data were employed to establish constitutive models of healing infarcts in 
the rat model. Finite element (FE) model and genetic algorithm (GA) were employed to identify 
the parameters of Fung orthotropic hyperelastic strain energy function for the healing infarcts. GA 
is a powerful tool for global optimization of complex problems and, when combined with FE 
modelling, provides an effective approach for solving inverse problems.  




Within the physiological range of biaxial strains and when Fung orthotropic model is utilized, FE 
models of myocardial tissue are insensitive to the density of transmural fibre layers or the element 
type. The identified material constants provide new platform for FE investigations of mechanical 
aspects of MI and therapies in particular when using rat models.  
7.1.4 Micromechanics of injectate during diastole 
A realistic micro-structurally detailed model of tissue and hydrogel developed from histology 
images was utilized in FE analysis of biomaterial injectate. We demonstrated that the 
micromechanics of biomaterial injectate can provide important information and help understand 
the mutual mechanical effect between the infarct tissue and the injected material. 
Good correlation was found between the predicted mechanics at such microscopic level with 
macroscopic finding from other studies. Focusing on the diastolic phase of the cardiac cycle, we 
found that increasing the stiffness of the injectate had an undesirable effect. We suggest a 
micromechanical mechanism by which the injectate reduces the infarct stress during the passive 
diastolic filling; the gel acts as attenuating system reducing the forces exerted on the fibres of the 
infarcted tissue. The predicted mechanics of gels revealed a sensitivity to change in the infarct 
properties during healing.  
7.2 Recommendations  
The work presented in this thesis can possibly be extended in several ways. 
7.2.1 Injectate 3D model 
Incorporating realistic 3D geometry of biomaterial injectate in FE models is feasible from 
histology micrographs. Yet, this approach has two limitations: 1) the subjectivity in the alignment 
of histology images prior to 3D reconstruction, and 2) the relatively low longitudinal (slice-to-slice) 
resolution. Although obtaining higher longitudinal resolution from histology micrographs may be 
possible, it is challenging both in the histological workup and in the image reconstruction (in 
particular image alignment). Therefore, examining other techniques to obtain images of sections 
from the intact (i.e. non-sectioned) hearts is highly recommended.  
The in vivo imaging methods can provide essential data to assess the change in the injectate 
geometry during cardiac cycle. Ex vivo imaging of the explanted heart is also a possible alternative. 
Reconstructing the injectate geometry from an explanted heart using micro computed tomography 
(micro-CT), for example, is a suggested approach although gel visibility in x-rays might be 




challenging. Arresting the heart at end-diastole and end-systole and utilizing micro-CT for obtain 
image data can also allow the assessment of the change in injectate geometry during cardiac cycle. 
Kadner et al. (2012) showed that the in situ injectate geometry can vary substantially when 
delivered at different time points after the infarct induction. The current study focused at the 
immediate injection whereas injectate geometries for delayed injections can be subject of future 
research. 
7.2.2 Mechanical testing and constitutive modelling 
In terms of mechanical testing, examining the infarct mechanical behaviour under shear loading 
can provide important data. Such data can be incorporated in constitutive modelling of the infarct. 
It will also help assessing the impact of the gel injectate on shear stress. 
Additionally, testing infarct samples using a triaxial (3-axis) testing system is suggested, despite the 
difficulties related to sample size, such as the one recently proposed by Hill et al. (2014). Triaxial 
testing of rat infarcts, if feasible, will allow for adequate 3D constitutive modelling for the 
orthotropic myocardial infarct. 
Another interesting extension of the current work includes the quantification of the orientation of 
collagen fibres in individual samples and the overall orientation for the different infarct groups. 
Such data may help in understanding the underlying mechanisms leading to the mechanical 
behaviour observed in the various phases of infarct healing. Also such information can be 
incorporated in the inverse model which will improve the accuracy of the identified parameters. 
7.2.3 Micromechanics of biomaterial injectate in systole 
We investigated the micromechanics of biomaterial injectate during the diastolic phase of the 
cardiac cycle. Implementation of active contraction in the constitutive model and investigation of 
the infarct-gel composites during systole is a potential extension of the current work. Also instead 
of modelling the gel and infarct as separate elements set in one model, contact can be applied 
through finding the friction coefficient of hydrogel on myocardial tissue. Additionally, utilization 
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